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Abstract
Central Line-Associated Bloodstream Infection (CLABSI) is a preventable issue in healthcare.
CLABSI contributes to negative patient outcomes and increased healthcare cost. Research
demonstrates that many interventions are effective in reducing the rate of CLABSI. The
implementation of CLABSI bundles can significantly reduce the occurrence of CLABSI. This
quality improvement project implemented a CLABSI bundle that specifically targeted identified
areas of weakness in CLABSI prevention at an organization with a focus on adult oncology care.
The three part CLABSI prevention bundle focused on: (a) registered nurses (RN) changing and
documenting endcaps in the electronic health record after blood administration, (b) RNs asking
about the necessity of central lines during daily rounds and encouraging the removal of
unnecessary central lines with the interdisciplinary team, including the physician, and (c) RNs
and nurse technicians (NTs) prioritizing and providing chlorhexidine (CHG) baths to patients
with central venous catheters daily. Two conceptual models were used to provide a framework
for implementation. A pre-post quiz was provided to staff members before and after CLABSI
education. Implementation took place over one month. Results yielded a 19.2% (76.6% [n=32] to
95.8% [n=30], p-Value=0.0015) increase in CLABSI prevention knowledge after education,
89.0% (0% [n=7] to 88.9% [n=18], p-Value <0.0001) endcap change rate, 91.2% (0% [n=8] to
91.2% [n=102], p-Value <0.0001) rate for assessing central line necessity during rounds, and
CHG bathing at 83.8% (81.2% [n=445] to 83.8% [n=115], p-Value>0.05). No CLABSI were
noted during the implementation phase.

Keywords: CLABSI, prevention, central venous catheter CVC, oncology
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Executive Summary
Adult oncology patients with central venous catheters (CVC) are at an increased risk for
central line-associated bloodstream infections (CLABSI). CLABSI is a healthcare associated
infection (HAI) that is preventable. The acquisition of a CLABSI can lead to devastating patient
outcomes including increased cost of care, increased length of stay, and potentially death
(Marschall et al., 2014; Crnich, 2010). In addition, the Center for Medicare and Medicaid
Services will not reimburse hospitals for the cost of CLABSI, which makes CLABSI very costly.
The United States spends up to an estimated 18.2 billion dollars each year on CLABSI costs
(Shah et al., 2016). CLABSI has a large impact on patient outcomes and evidence-based
interventions should be put in place to reduce risk for CLABSI.
A Midwest healthcare organization with an adult oncology bone marrow transplant
population identified an issue with elevated CLABSI rates. This Doctor of Nursing Practice
(DNP) scholarly project aimed to answer the question: what are the best evidence-based
CLABSI prevention interventions for CVC maintenance that are feasible and sustainable for the
organization? An organizational assessment and a literature review on CLABSI prevention
toolkits was completed. This informed the development of a new CLABSI bundle with
interventions to target the identified areas of risk for CLABSI at the organization. The proposed
CLABSI quality improvement project aimed to prevent or reduce CLABSI, increase quality of
care, and decrease length of stay and costs of care.
There were three objectives for the project. First, registered nurses (RNs) will change
and document endcaps in the electronic health record (EHR) after blood administration. Second,
RNs will ask about the necessity of central lines during daily rounds and encourage the removal
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of unnecessary central lines with the interdisciplinary team. Finally, RNs and nurse technicians
(NTs) will prioritize and provide chlorhexidine (CHG) bathing to patients with CVCs daily.
These objectives were met by following specific implementation strategies. This included
providing education to RNs and NTs regarding CLABSI prevention, workflow change on the
unit, daily auditing and feedback, and ongoing training for RNs and NTs (Powell et al., 2015).
The DNP student conducted measurement of the CLABSI prevention bundle implementation. A
pre- and post-quiz was given to RNs and NTs on the unit to determine effectiveness of
education. The student also collected data observed in daily rounds about RNs asking if
unnecessary CVC could be removed, audited EHR charting to determine if endcaps were
changed after blood administration, and audited EHR charting to determine if patients with
central lines were bathed daily in CHG. The number of CLABSI during the intervention was also
tracked as this is usually done by the organization.
The data collected during the project showed a 19.2% increase in score from the pre-quiz
to the post-quiz. This indicated an increased level of CLABSI prevention knowledge. End cap
audit data indicated 88.9% (n=16) endcaps being changed after blood products and 11.1% (n=2)
were not changed after blood products. Line removal audits noted 91.2% (n=93) observed rounds
where RNs asked about the necessity of CVCs and 8.8% (n=9) where CVCs were not discussed.
Chlorhexidine bathing was measured two ways. The first measurement was a strict measurement
according the DNP student standard of either “yes” or “no” for a patient being bathed daily in
CHG. It was noted that 63.6% (n=63) patients did have CHG bathing while 36.4% (n=36) did
not. The second measurement was per the unit’s standard. The unit standard/measure of bathing
counted “yes” for bathed with CHG even if CHG was not charted, or if a patient refused bathing
twice in a day; and a “no” with no bath at all or only being charted as refused once. The unit
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standard showed 83.8% (n= 83) of patients did have CHG bathing while n= 16 (16.2%) did not.
No CLABSI were noted during the intervention.
Overall, the implementation of the three part CLABSI bundle is considered a success.
Each of the components measured was increased from the prior data collection before
implementation. The prevention of CLABSI improves patient outcomes and decreases the cost of
care.
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Prevention of Central Line-Associated Bloodstream Infection (CLABSI) in Adult Oncology
Patients
A central line is an intravascular catheter that terminates close to the heart, that is located
in one of the great vessels, and used for infusion, withdrawal of blood, or hemodynamic
monitoring (Center for Disease Control [CDC], 2017). Central lines are necessary to deliver
lifesaving medications, hemodynamic support, and for long-term chemotherapy (Shah, Schwartz,
& Cullen, 2016). A central line-associated bloodstream infection (CLABSI) is a laboratoryconfirmed bloodstream infection. CLABSI can lead to negative patient outcomes and increased
healthcare cost. The average cost of a CLABSI ranges from $3,700 to $39,000 and can extend
the hospital length of stay up to 20 days (Marschall et al., 2014; Crnich, 2010). The annual
cumulative cost of CLABSI in the United States is estimated to range from 960 million to 18.2
billion dollars (Shah et al., 2016). An estimated 84,551 to 203,916 CLABSI are known to be
preventable (Johns Hopkins University Quality and Safety Research Group [QRSG], 2009a). In
addition, there are an estimated 10,426 to 25,145 preventable deaths in the United States that are
CLABSI related (Johns Hopkins University QRSG, 2009a).
CLABSI prevention is key to providing safe care for patients. Patients are at an increased
risk for CLABSI when they have a prolonged hospitalization prior to catheter insertion,
prolonged catheter duration, internal jugular or femoral insertion site, neutropenia, total parental
nutrition, reduced nurse to patient ratio, or microbial colonization at the insertion site or hub
(Marschall et al., 2014). The prevention of CLABSI is important; patients with CLABSI are
twice as likely to die as patients without CLABSI (Stevens et al., 2014).
A Midwest healthcare organization has identified an increase in the number of CLABSI
cases present in adult oncology patients. An organizational assessment using the Burke-Litwin
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Model of Organizational Performance and Change (1992) was conducted, which identified many
areas that could be addressed to decrease CLABSI. A literature review of evidence-based
CLABSI toolkits was conducted to identify interventions to prevent CLABSI. The common
theme from the toolkits will be implemented in the organization to mitigate the present gap in
practice that could be leading to CLABSI. The literature supports an evidence-based initiative to
reduce CLABSI. The purpose of this quality improvement project was to reduce the number of
CLABSI in this organization by implementing evidence-based interventions with a CLABSI
bundle that creates culture and practice change, thereby reducing the rate of CLABSI.
Problem Statement
CLABSI is a risk for patients that are hospitalized. The current estimate is that 4.4 out of
100 people with central lines will acquire a CLABSI (Blot, Bergs, Vogelars, Blot, & Vandijck,
2014). Patients infected with CLABSI accumulate cost of care due to expensive antibiotic
therapy and are at increased risk for death due to sepsis (Shah, Schwartz, Luna, & Cullen, 2016).
In order to encourage CLABSI prevention, the Center for Medicare and Medicaid does not
reimburse hospitals for the cost of CLABSI. CLABSI prevention is crucial, particularly in the
adult bone marrow transplant population, which has a 36% incidence rate of bloodstream
infection as compared to 1% in the ICU population (Boubekri, 2013).
A Midwest healthcare organization with an adult oncology bone marrow transplant
population identified an issue with increased CLABSI rates. The organization has cancer patients
that are high utilizers of central venous catheters (CVCs), and sought a solution to decrease the
rate of CLABSI. The following question will be asked. What are the best evidence-based
CLABSI prevention interventions for CVC maintenance that are feasible and sustainable for the
organization? Review of the literature on CLABSI prevention strategies and evidence-based
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CLABSI toolkits informed the development of a new CLABSI bundle with interventions to
target the identified areas of risk for CLABSI in the organization. These risk areas include
changing and documentation of the CVC endcap after receiving blood products, prioritizing of
daily bathing in chlorhexidine gluconate (CHG) for patients with a CVC, and asking if CVCs can
be removed in daily rounds. The proposed CLABSI quality improvement project will aim to
prevent or reduce CLABSI, improve quality of care, and decrease length of stay and cost of care.
Literature Review
A CLABSI is a laboratory-confirmed bloodstream infection that meets the criteria of the
CDC (see Appendix A). CLABSI can lead to negative patient outcomes and increased healthcare
cost. The average cost of a CLABSI ranges from $3,700 to $39,000 and can extend hospital
length of stay up to 20 days (Marschall et al., 2014; Crnich, 2010). An estimated 84,551 to
203,916 CLABSI are known to be preventable (Johns Hopkins University Quality and Safety
Research Group (QSRG), 2009a). In addition, there are an estimated 10,426 to 25,145
preventable deaths in the United States that are CLABSI related (Johns Hopkins University
QSRG, 2009a). CLABSI prevention is key to providing a safe care for patients. The purpose of
this literature review is to report on evidence-based CLABSI prevention toolkits. The review will
focus on CLABSI prevention during the maintenance period, after the line is inserted.
Aim
This literature review reports on evidence-based CLABSI toolkits from three sources:
The Joint Commission, CDC, and Johns Hopkins. Each toolkit was evaluated and common
themes identified and reported. Findings of this review identified recommendations for a
CLABSI prevention toolkit for organizations that have identified a safety issue regarding
CLABSI.
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Methods
An Internet search for evidence-based CLABSI toolkits was conducted from August to
September 2017. Four CLABSI prevention toolkits were identified: The Joint Commission,
CDC, Johns Hopkins, and AHRQ (Appendix B). The AHRQs toolkit was excluded as it was the
same toolkit content published by The Joint Commission. Each toolkit was individually
evaluated. This included, examining the definition of CLABSI, toolkit inclusion and exclusion
criteria, and design and categorization of the prevention toolkit interventions. Components of the
toolkits were listed. Collaborating organizations, supplemental tools and checklists were
examined. Specific criteria regarding prevention methods were clarified, and limitations were
listed. Findings from this review are presented. Synthesis of these toolkits led to
recommendations for healthcare settings where CLABSI prevention is needed.
Findings
Three CLABSI prevention toolkits were included in this review. Appendix C shows the
interventions recommended to prevent CLABSI. Each toolkit includes: collaborating
organizations, a CLABSI definition, inclusion and exclusion criteria, design and categorization
of the intervention, structure of the toolkit, references, supplemental tools and checklists, specific
criteria on prevention methods, and limitations. These interventions will be reviewed in the
following sections.
The joint commission toolkit.
The Joint Commission created a CLABSI Toolkit to supplement a prior monograph
entitled “Preventing Central Line-Associated Bloodstream Infections-A Global Challenge” (The
Joint Commission, 2017a; The Joint Commission, 2012). The toolkit focused on central lines and
is intended for use by healthcare personnel. The goal of the toolkit is to provide the current
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evidence-based interventions regarding preventing CLABSI (The Joint Commission, 2017a).
The toolkit is publically available online at
https://www.jointcommission.org/assets/1/18/CLABSI_Monograph.pdf, and includes tools,
resources, and educational modules for healthcare personnel.
Collaborating organizations. The Joint Commission, Joint Commission Resources, and
Joint Commission International collaborated to create the CLABSI toolkit (The Joint
Commission, 2017a). Numerous resources were used from other organizations with permission.
This included, the CDC, World Health Organization, AHRQ, Johns Hopkins University, and
several medical centers (The Joint Commission, 2017d).
Definition of CLABSI. The Joint Commission Toolkit defines CLABSI in the glossary
section. The definition of CLABSI is adopted from the National Healthcare Safety Network
(2012). The definition is: “Primary bloodstream infection in the presence of a central line or
umbilical catheter at the time of, or within 48 hours before, onset of the infection. Additionally,
“with no other source of infection evident other than the catheter”. Finally, “there is no minimum
period of time that the central line must be in place in order for the bloodstream infection to be
considered central line associated” (The Joint Commission, 2017b).
Inclusion/exclusion criteria. Inclusion and exclusion criteria for CLABSI prevention
intervention selected are not listed in the toolkit.
Design and categorization of evidence. The acknowledgments section of the toolkit
provides detailed information on how the toolkit was developed. The Joint Commission
Technical Advisory Panel examined the evidence and provided expert feedback throughout
creation of the toolkit. The staff from The Joint Commission who worked on the toolkit are also
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listed (The Joint Commission, 2017c). The information provided in the toolkit is not categorized
by a level of evidence schema.
Toolkit structure. The Joint Commission Toolkit includes an introduction, 6 chapters, a
glossary, directory of tools, acknowledgements, a disclaimer, and a link to the original
monograph (The Joint commission, 2017a). The introduction identifies central venous catheters
CVCs as the most frequent cause of healthcare infections. Chapter 1 discusses types of central
venous catheters, CLABSI risk factors, and the pathogenesis of CLABSI. Chapter 2 emphasizes
the background of CLABSI including: barriers to best practice, position papers from
organizations that present evidence to support their opinion, clinical practice guidelines, and
initiatives and campaigns for CLABSI prevention. Chapter 3 focuses on CLABSI prevention and
will be discussed in detail later. Chapter 4 concentrates on patient safety initiatives. Chapter 5
includes surveillance, benchmarking, and reporting. Chapter 6 provides the economic impact of
CLABSI and why CLABSI prevention is essential. The glossary includes links to definitions of
unfamiliar terms. The directory of tools has links to access tools from The Joint Commission and
other organizations.
Supplemental tools and checklists. There are several supplemental tools available in this
toolkit in the Toolkit Tools Directory (The Joint Commission, 2017d). A daily central line
maintenance checklist [(see Appendix E) The Joint Commission, 2017d] is included in the
directory. This checklist was selected to be reviewed as it focuses on central line maintenance
and prevention of CLABSI once the line is already in place. The checklist is available as a word
document. Items included in the checklist are: patient name, unit, room, date, person completing
from, date of line placement, date accessed, date injection cap(s) last changed, date
administration set last changed, and what the administration set was used for. The date the
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dressing was last changed, including the type of dressing, are also included. The checklist has 9
items that be completed, that are critical to preventing CLABSI. These includes: if the injection
site is covered by a cap or a valved connector, if cap(s) changed today, accessed with (indicate
type and size of needle), insertion site without evidence of infection, dressing intact and labeled
properly, dressing changed today, catheter stabilized/no tension on line, administration set
replaced and labeled this time. Each item has a yes or no option, and a comment section is
available (The Joint Commission, 2017e).
CLABSI prevention maintenance methods. Chapter 3 of the toolkit focuses on CLABSI
prevention strategies, techniques, and technology that can be used to support care. This includes
insertion of CVC and maintenance techniques. However, this section of the review will focus
solely on CLABSI prevention during the maintenance period.
The toolkit includes that catheter hubs, injection ports, and connectors should be
disinfected prior to use. It is also noted, that closed catheter systems are associated with fewer
infections. A tool is provided that reviews proper steps for disinfecting a hub. Chlorhexidine with
alcohol or 70% alcohol are recommended for use when disinfecting, in addition to scrubbing for
15 seconds (Ryder 2011; Sweet, Cumpston, Briggs, Craig, & Hamadani, 2012). Prophylactic
antibiotic lock solutions, antimicrobial flush solutions, and catheter lock solutions are not
recommended for use on central lines (The Joint Commission, 2017g). The Joint Commission
states support for the CDC recommendation that all patients in the intensive care unit (ICU) over
two months of age be bathed daily with 2% chlorhexidine. A CVC maintenance bundle, and
daily central line maintenance checklist are included. The CVC maintenance bundle includes
combining several prevention methods to reduce CLABSI. Included in the suggested
interventions in the CVC maintenance bundle is changing the administration set immediately
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after blood products. Also, using aseptic technique when accessing the catheter, educating
healthcare personnel, and daily review of line necessity with prompt removal of unnecessary
CVCs is included in the bundle. Lastly, hand hygiene and changing clear dressings every 7 days
is endorsed (The Joint Commission, 2017i).
In addition, a Comprehensive Unit Based Safety (CUSP) central line maintenance audit
form and event-reporting template are included. These resources are linked to the AHRQ
website. A link to CVC removal considerations is also included. The CVC removal
considerations provides a list of questions to ask to consider the removal of a central venous
catheter (The Joint Commission, 2017h). Additional links to tools that can be used for individual
or organizational self-assessment and CUSP care of patients with different types of lines are
included (The Joint Commission, 2017g).
Limitations. One limitation of The Joint Commission toolkit is the lack of leveling of
evidence. In addition, the inclusion and exclusion criteria are not readily accessible. The Joint
Commission also notes that the toolkit is based on the monograph and toolkit staff did not
conduct an additional systematic literature review after the monograph was published in 2012
(The Joint Commission, 2017f).
Center for disease control toolkit.
The CDC provides several healthcare associated infection prevention resources. One such
resource is for CLABSI prevention. The website provides a link to a checklist, which is entitled
“Checklist for Prevention of Central Line Associated Bloodstream Infections” (CDC, 2017d).
The checklist is based on the 2011 CDC guideline for prevention of intravascular catheterassociated bloodstream infections. The 2014 update of strategies to prevent central lineassociated bloodstream infections in acute care hospitals was also used to create the toolkit.
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(O’Grady et al., 2011; Marschall et al., 2014). The checklist includes recommendations for
clinicians and for healthcare organizations.
Collaborating organizations. Fifteen professional organizations created a working group
that collaborated to create the 2011 CDC guidelines for the prevention of intravascular catheterrelated infections, which was then utilized to create this toolkit. This included the Society of
Critical Care Medicine, Surgical Infection Society, American College of Chest Physicians,
American Thoracic Society, American Society of Critical Care Anesthesiologists, Association
for Professionals in Infection Control and Epidemiology, Infusion Nurses Society, Oncology
Nursing Society, American Society for Parenteral and Enteral Nutrition, Society for
Interventional Radiology, American Academy of Pediatrics, Pediatric Infectious Diseases
Society, and the Healthcare Infection Control Practices Advisory Committee (O’Grady et al.,
2011).
Definition of CLABSI. The definition is not specified (CDC, 2017b). Two links on the
checklist refer to the 2011 CDC guidelines for the prevention of intravascular catheter-associated
bloodstream infections and an article about strategies to prevent CLABSI (O’Grady et al., 2011;
Marschall et al., 2014). However, neither document provides an explicit definition of CLABSI.
For the definition of CLABSI available on the CDC website (see Appendix A).
Inclusion/exclusion criteria. The inclusion and exclusion criterion are not specifically
listed. The CDC guidelines (2011) include a notation that indicates the CDC and Healthcare
Infection Control Practices Advisory Committee worked collaboratively to create the guideline.
Unfortunately, the hyperlink to their inclusion/exclusion methodology is no longer active
(O’grady et al., 2011).
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Design and categorization of evidence. The 2011 CDC guidelines include a category
rating schema. There are five categories (IA, IB, IC, II, or unresolved issues). Category IA
strongly recommends intervention, as it is supported by experimental, clinical, or
epidemiological research. Category IB also strongly recommends an intervention as it is
supported by some clinical, experimental, or epidemiology research and theory or accepted
practice. Category IC are interventions required by federal or state rules and regulations.
Category II are interventions suggested for implementation supported by theory or some clinical
or epidemiologic studies. Lastly, the category, unresolved issue, indicates evidence that is
insufficient or with no consensus (O’Grady et al., 2011). Each CDC intervention for CLABSI
prevention is presented below.
Toolkit structure. The toolkit includes a checklist with two main sections: one for
clinicians and another for healthcare organizations (see Appendix F). The clinician checklist
section is divided into 3 sections: follow proper insertion practices, handling and maintaining
central lines, and prompt removal of unnecessary central lines. Each sub-section includes actions
for providers to follow to prevent CLABSI (CDC, 2017b). The organization portion of the
checklist includes a main section with supplemental strategies for consideration. The checklist
has two hyperlinks to resources used to create it (O’grady et al., 2011; Marschall et al., 2014).
Supplemental tools/checklists. This toolkit does not provide additional tools or
checklists. The toolkit is comprised of one checklist and two source references from which the
checklist was created.
CLABSI prevention maintenance methods. The checklist provides clinician steps for
handling lines and maintaining central lines properly. This section will list each step provided
along with the evidence-based categorical rating found in the CDC 2011 Guidelines. The
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following items are included on the checklist. Comply with hand hygiene requirements (category
IB). Bathe ICU patients over 2 months of age with a chlorhexidine preparation daily (II). Scrub
the access port or hub with friction before accessing with appropriate antiseptic (IB). Use only
sterile devices to access catheters (IB). Immediately replace wet, dislodged, or soiled dressings
(IB). Preform dressing change with sterile technique (IA). Change gauze dressings every two
days (II) and semipermeable dressings every seven days (IB). Adults 18 years of age or older
should use chlorhexidine impregnated dressing with FDA clear label that includes indication for
central line (IB). Change continuous administration sets no more frequently than every 4 days,
but at least every 7 days (IA). If blood products or fat emulsions given change administration set
every 24 hours (IB). If propofol administered change tubing every 6-12 hours or when vial is
changed (IA) (O’Grady et al., 2011).
The checklist also recommends preforming a daily audit to determine if the central line
is needed and to remove unnecessary central lines. A category rating was not provided for central
line removal in the 2011 CDC Guidebook, but Marschall and colleagues (2014) graded removal
of nonessential catheters as a Level II based on a I-III grading scale from the Grades of
Recommendation, Assessment, Development, and Evaluation (GRADE) and Canadian Task
force on Preventative Healthcare. A grade II is moderate: there are a few studies with evidence
and some have limitations, or there is variation between studies, or a wide confidence interval
(Marschall et al., 2014).
limitations. Limitations include a lack of a definition for CLABSI, although a definition
was found on the website. In addition, the checklist included interventions to prevent CLABSI,
but the intervention strength of evidence were not on the checklist form. No inclusion or
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exclusion criteria were specified as to how checklist items were selected from the toolkit as the
toolkit encompassed more interventions than those that were listed on the checklist.
Johns Hopkins university toolkit.
Johns Hopkins University created the “On The CUSP: STOP BSI Central LineAssociated Blood Stream Infection Toolkit” (Johns Hopkins QSRG, 2009b). The toolkit focuses
on a 4-part model, engage, educate, execute, and evaluate. Engage involves making staff
understand the reality of the problem.
For example, this would include the number of CLABI in the clinical area, opportunity to
improve, and providing benchmarking and performance data. Education includes making sure
that staff understand their role in reducing CLABSI. Guideline and nursing interventions should
be included. Execute includes a five step process listed in the CLABSI toolkit. First, staff should
be educated using a CLABSI fact sheet. Second, a line insertion cart should be created. Third,
providers should be asked daily if catheters could be removed. Fourth, implement a checklist
during catheter insertion to ensure guideline adherence. Fifth, empower staff to stop insertion
procedure if there is a violation observed. Evaluate includes collecting CLABSI data before and
after the toolkit implementation.
Collaborating organizations. There were multiple collaborating organizations that
developed the toolkit. First, AHRQ, the Health Research and Educational Trust, the Keystone
Center for Patient Safety and Quality of Michigan Health and Hospital Association, and the
Armstrong Institute of Johns Hopkins implemented the comprehensive unit based safety program
(CUSP).
Definition of CLABSI. The definition of CLABSI is not included. However, a definition
for laboratory confirmed bloodstream infection is provided [(see Appendix A) (Horan, Andrus,
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& Dudeck, 2008)]. A CLABSI occurs when the central line was in place for at least 2 calendar
days on the date of event, with day of device placement being day 1, and the line was also in
place on the date of the event or day before. Also, if the central line was in place for at least 2
calendar days and then removed, the date of event of the laboratory-confirmed bloodstream
infection must be the day of discontinuation or the next day to be a CLABSI (CDC, 2017a).
Inclusion/exclusion criteria. The inclusion and exclusion criteria for this toolkit were not
explicitly listed within the toolkit or on the webpage. This toolkit was created based on “An
Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU,” which targeted
five CDC recommended interventions: hand washing, using full barrier precautions during the
insertion of central venous catheters, cleaning the skin with chlorhexidine, avoiding the femoral
site, and removing unnecessary lines (Pronovost et al., 2006). These factors are also listed in the
Execute section of the Toolkit (Johns Hopkins QSRG, 2009b).
Design and categorization of evidence. The toolkit Appendix B provides a fact sheet that
includes each recommended intervention with a rating from the Society for Healthcare
Epidemiology of America and Infectious Disease Society of America Practice Recommendation:
Strategies to Prevent Healthcare- Associated Infections in Acute Care Hospitals (Marschall et al.,
2008). The strength of recommendation is A (good evidence), B (moderate evidence), or C (poor
evidence), and the Quality of Evidence I (evidence from more than one randomized control trial),
II (evidence from studies without a controlled clinical trail), III (evidence from opinion, clinical
practice, descriptive studies, or expert committees). The ratings for the interventions are as
follows: appropriate hand hygiene (B-II), the use of chlorhexidine for skin preparation (A-I), use
of full barrier precautions during central line insertion (A-I), avoiding femoral vein locations (AI), and removing unnecessary central lines (A-II).
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Toolkit structure. The toolkit is comprised of a main body, which includes the previously
mentioned elements of engage, educate, execute, and evaluate. In addition, there are 25
appendices to assist with CLABSI prevention and an article that toolkit is based on (Johns
Hopkins QSRG, 2009b; Pronovost et al., 2006). The appendices and description can be viewed
(see Appendix D).
CLABSI prevention maintenance methods. This toolkit includes a daily goals checklist
for nursing. Specific to CLABSI prevention, this checklist includes an item asking if the central
line can be removed with a yes/no box. Removing central venous catheters in the primary
method of prevention mentioned in this toolkit while in the maintenance period (Johns Hopkins
QSRG, 2009b).
limitations. One limitation is that a definition of a CLABSI is not included. Also,
inclusion and exclusion criteria are not listed within the toolkit. As it pertains to this review, a
limitation is that the toolkit focuses on five main interventions, which primarily pertain to central
line insertion rather than prevention of CLABSI during the maintenance period, after the central
line has been inserted. However, it was included as it did touch on CLABSI prevention during
the maintence period as an element was asking about central line remival daily.
Discussion of Common CLABSI Prevention Toolkit Components
A key finding of this toolkit literature review is that there are several evidence-based
CLABSI prevention methods that can be utilized. Each toolkit is unique in design and content.
The findings of this review indicated that there is a high level of evidence for hand hygiene and
promptly removing unnecessary central lines (Johns Hopkins QSRG, 2009b; O’Grady et al.,
2011; The Joint Commission, 2017i). There is also support for bathing ICU patients over 2
months of age with chlorhexidine preparations daily, changing semipermeable dressings every 7
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days, scrubbing access ports/hubs with antiseptic before accessing, and changing administration
sets every 24 hours after blood products or emulsions are given (O’Grady et al., 2011; The Joint
Commission, 2017i). See Appendix C for each organization’s CLABSI prevention maintenance
methods. Each organization collaborated with other organizations to create the published toolkits
and provided varying definitions for CLABSI. Although the three definitions for CLABSI were
not consistent, they were very similar conveying the meaning of CLABSI and easily interpreted.
All three CLABSI toolkits included a daily central line checklist for nursing to use in
practice. The Joint commission daily central line maintenance checklist (see Appendix E) was
more related to central line prevention as compared to the Johns Hopkins daily goals checklist
(see Appendix I), which only included one item, central line removal, related to CLABSI
Prevention (The Joint Commission, 2017d; Johns Hopkins QRSG, 2009b). The CDC CLABSI
checklist (see Appendix F) included evidence-based daily maintenance interventions for central
lines.
A limitation of this review was a lack of inclusion and exclusion criteria explicitly listed
for the CLABSI toolkits. Future research could focus on evaluating how the interventions for
each toolkit were included or excluded. In addition, a schema or level of evidence was not
provided for The Joint Commission toolkit. The interventions recommended in this toolkit could
be further evaluated supporting level of evidence.
Relevance to Clinical Practice
This review was conducted to discover commonalities and evidence-based interventions
in CLABSI toolkits presently available for use in the healthcare setting. At the conclusion of this
review, several evidence-based interventions were identified across all toolkits reviewed to
prevent CLABSI during the maintenance period. The toolkits often included similar
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interventions and every toolkit included daily nursing maintenance checklists. There is a dearth
of evidence to support the use of CLABSI prevention interventions and an urgent need to
decrease CLABSI. These toolkits can be implemented at healthcare organizations to help lower
CLABSI rates.
Conclusion
CLABSI are preventable and lead to poor patient outcomes and increased healthcare
costs. Yet, CLABSI remain a major healthcare concern. This review examined evidence-based
CLABSI toolkits from three sources: The Joint Commission, CDC, and Johns Hopkins
University. Each toolkit included different evidence-based interventions to prevent CLABSI.
Nurses should be aware of the evidence-based interventions when caring for patients with a
central line, and use that information to guide decision making in clinical practice. Evidencebased intervention prevention strategies found in CLABSI toolkits can be utilized to help prevent
CLABSI during the central line maintenance period.
Evidence-Based Initiative
The literature review comprehensively examined evidence for preventing CLABSI
during the central line maintenance period. Additional evidence supporting the use of daily CHG
bathing, changing administration sets after blood administration, and daily discussion of central
line removal will be presented. This evidence was utilized to create a CLABSI prevention bundle
for this project.
Daily chlorhexidine bathing.
Skin colonization of bacteria and other organisms facilitate the transmission of harmful
organisms into the central line. Chlorhexidine gluconate can reduce the skin microbial burden
(O’Horo, Germana, Munoz-Price, & Safdar, 2012). CHG is effective against gram-positive
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bacteria, gram-negative bacteria, aerobic and anaerobic bacteria, and yeasts (Kim et al., 2016).
CHG lasts for up to 24 hours (Shah et al., 2016). CHG can be applied directly to the skin as a
liquid solution mixed with water or as an impregnated clean washcloth (Karki & Cheng, 2012).
A limitation to CHG use may be the development of allergic skin reactions (Karki & Cheng,
2012). There are several studies that focus on CHG use to prevent CLABSI in the adult
population.
A meta-analysis of CHG bathing on health care associated infections, including 18
studies: 6 randomized clinical trials (RCT) and 12 interrupted time series trials (ITS), noted that
the acquisition of CLABSI was reduced. These studies compared CHG bathing to usual care,
bathing with soap and water. The CHG bathing group had over 50% reduction in CLABSI as
compared to the conventional care group (Kim et al., 2016). Limitations of this meta-analysis
include the inclusion of many non-randomized studies with an ITS design. Also, the intervention
groups used both CHG wipes and CHG liquid solution with water. The portion of CHG to water
was not reported in 3 studies.
Shah and colleagues (2016) also conducted a systematic review on 2% CHG bathing of
patients in the ICU with central lines. Six studies were included in the synthesis and 4 in the
meta-analysis. The studies compared CHG bathing to soap and water bathing. The CHG group
had a RR ratio of 0.46. This study was limited by the small sample size.
Another systematic review and meta-analysis by Frost (2016) and colleagues identified
that CLABSI decreased by 56% when CHG was used. This study included 17 trials: 11 cluster
randomized crossover trials and 6 before and after trials.
In addition, a systematic review about prevention of HAI with CHG included 20 total
studies. Eight specifically focused on CLABSI. All studies included 2% CHG washcloths to
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normal soap and water bathing. Five studies showed significant reduction in CLABSI while 3
did not show any change in CLABSI rate. Compared to soap and water bathing, CHG bathing
significantly reduced the rate of CLABSI: pooled IRR 0.43 (Karki & Cheng, 2012). This metaanalysis is limited as it included a small number of studies, many of which were non-randomized
and also the studies did not report adherence to CHG use.
A meta-analysis conducted noted that CHG bathing, whether liquid or cloths, provided
benefit in preventing CLABSI. 12 studies were included, 1 RCT and 11 quasi-experimental
(O’Horo et al., 2012). Lastly, in an ITS multiple site study that implemented CHG bathing,
hospitals demonstrated a 59% decrease in the rate of CLABSI (Dicks et al., 2016). This study
focused on adults in the ICU and noted that a limitation included not being able to assess
adherence to daily CHG bathing.
One RCT by Noto and colleagues (2015) resulted in CHG bathing not reducing the
incidence of CLABSI. This article had many limitations including the study not being blinded,
daily bathing adherence not assessed, and a short median stay may have influenced the outcomes
of the study. It is notable that other meta-analysis that included the Noto and colleagues study
(2015) still found CHG bathing to be an effective method of CLABSI prevention (Kim et al.,
2016). There is overwhelming evidence form many meta-analysis and meta-synthesis that the
use of CHG bathing does decrease the rate of CLABSI.
Assessing daily for central line removal.
Marschall and colleagues (2014) published strategies to prevent CLABSI in acute care
hospitals. Within this guide, removing non-essential catheters is given a level II out of III grade.
A level II grade indicates that evidence is moderate when there are only a few studies and some
have limitations, but not major flaws, there is variation between studies, or the confidence
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interval is wide. It is recommended that the need for the central line be assessed daily in
interdisciplinary rounds and that unnecessary catheters be removed. In addition, (Marschall et al.,
2014) recommend auditing if central lines were removed after their intended purpose is
completed.
Several studies have implemented daily assessment for line removal as part of a care
bundle or checklist and seen positive outcomes. Rutala and colleagues (2015) conducted a cluster
randomized controlled trial requiring a provider to indicate the reason for a central line each day.
If the provider did not provide the indication in the morning round, the charge nurse would
remind the provider to do so. This intervention decreased the number of central line days, but did
not show a decrease in CLABSI. Another multicenter, phased, cluster-randomized controlled
trial implemented a multifaceted intervention including removing unnecessary line to prevent
CLABSI. The bundle implemented was Johns Hopkins evidence-based bloodstream infection
bundle and the intervention group saw a 70% reduction in CLABSI (Marsteller et al., 2012).
Changing administration sets after blood products.
Blood products place a person with CVC at risk for infection for many reasons. Blood
products provide a welcoming environment for bacteria to grow. Platelets, a blood product, may
increase adherence of bacteria to the catheter wall. Platelets also pose a risk as several donors
contribute to one transfusion therefore increasing risk for transferring organisms (Hermann,
Albrecht, Mosher, & Proctor, 1992).
Receiving blood products through a CVC has shown to be an independent risk factor for
CLABSI. Hanna & Raad (2001) evaluated a study of risk factors for CLABSI by conducting
multiple logistic regression analysis and noted that the use of blood products through a CVC,
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including platelets, was an independent risk factor (p=0.17). It is important then, to consider
prevention strategies to reduce the rate of CLABSI developing from blood administration.
A Cochrane review evaluated the optimal timing for changing intravascular
administration sets (tubing and endcaps) for usual care and noted that changing administration
sets that did not contain blood products at a time range of up to 96 hours does not affect risk of
infection (Gilles, Wallen, Morrision, Rankin, Nagy, & O’Riordan, 2013). This study agreed with
CDC guidelines for changing blood administration and lipid administration sets. The 2011 CDC
guidelines for prevention of intravascular catheter-related infections recommend replacing
administration sets used to administer blood products within 24 hours of initiating the infusion
(O’Grady et al., 2011).
Overall, there is evidence to support CLABSI prevention with implementation of a care
bundle including CHG bathing, daily assessment and removal of unnecessary central lines, and
changing administration sets after receiving blood products. Each toolkit evaluated supported the
aforementioned three prevention methods and in addition, independent evidence also supports
the interventions. Based on the supporting evidence, it is reasonable to purport a CLABSI
prevention bundle including a focus on prioritizing CHG bathing for patients with central lines,
daily assessment and removal of unnecessary central lines, and changing administration sets after
receiving blood products.
Conceptual Model to Understand Phenomenon
Conceptual models can be utilized to create a trajectory or provide guidance for
understanding a phenomenon. The phenomenon of interest in this quality improvement project is
CLABSI prevention. Two conceptual models were used to provide direction, understand the
population at risk for CLABSI, and provide a framework for implementation that allows

29

evidence to be translated to practice. A CDC Framework for Preventing Infectious Diseases:
Sustaining the Essentials and Innovating for the Future (CDC’s ID Framework) and the
Promoting Action on Research Implementation in Health Services (PARIHS) framework were
both used to implement the CLABSI prevention care bundle.
CDC ID Framework
The CDC ID Framework was developed to provide a roadmap to improve and prevent
known infectious diseases and guide evidence-based policies. The ID Framework is designed to
be effective on a large scale, focusing on the United States public health system. This ID
framework aims to prevent diseases such as human immunodeficiency virus, influenza A virus,
and healthcare associated infections, which include CLABSI. The ID Framework consists of
three main elements that guide the process of disease prevention (see Appendix J). Element 1
strengthens public health fundamentals, including disease surveillance, laboratory detection, and
epidemiologic investigation. Element 2 focuses on identifying and implementing interventions to
reduce infectious diseases. Element 3 includes the development of policy to prevent, detect, and
control infectious diseases (CDC, 2011). Each of these elements will be evaluated as it pertains
to the implementation of the CLABSI prevention care bundle.
Element 1.
Health fundamentals, even at the local level, are important to protect people from disease.
These fundamentals include surveillance, detection, and investigation. In order to meet these
fundamentals, modernization of surveillance to drive action, expansion of laboratories, and
workforce development and training must occur. Surveillance data is necessary for monitoring
effectiveness, timeliness, and cost-effectiveness of present prevention strategies (CDC, 2011).
Surveillance will take place during this quality improvement project. Meaningful use of EHR
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data to monitor for effectiveness of the intervention, documentation CHG bathing, and endcap
changes after blood administration will be conducted. In addition, surveillance of asking about
removing unnecessary lines will occur during daily rounds. In particular, this project
implementation will focus on the advancement of workforce development and training to
strengthen infection prevention practice. Every RN at the organization will be provided CLABSI
prevention education and a thorough explanation of their role in implementing CLABSI
prevention bundle.
Element 2.
Implementing high impact interventions, such as tools for disease prevention, is
imperative. Identifying and validating new tools or implementing proven tools can both be
effective ways to reduce infection. The ID Framework notes that using proven tools and
interventions to reduce high burden disease, such as HAI, including CLABSI, is a priority. The
use of infection control toolkits for hospital personnel is specifically discussed (CDC, 2011).
This project has identified CLABSI toolkits that have evidence-based interventions to reduce
CLABSI during the maintenance period. Based on the organizations needs, a CLABSI care
bundle has been assembled including changing and documentation of the CVC endcap after
receiving blood products, prioritizing of daily bathing in chlorhexidine gluconate (CHG) for
patients with a CVC, and asking if CVCs can be removed in daily rounds.
Element 3.
Policy should reflect evidence-based practice and include key stakeholders. Policy should
be supported by scientific data and be cost-effective. It is important that awareness of policy and
individual engagement in prevention efforts occur (CDC, 2011). This quality improvement
project is not implementing a policy within the organization, but is implementing a CLABSI
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prevention bundle that will require individual engagement from RNs in order for the prevention
effort to be effective. If the CLABSI bundle implemented is effective, perhaps a new policy
could be implemented in the future based on evidence-based findings and interventions.
Summary.
The CDC ID Framework provides direction to prevent infection and create evidencebased policy. Utilizing the three elements of disease prevention, disease surveillance, disease
prevention, and implementing policy, may be effective in decreasing the risk of CLABSI.
PARIHS Framework
The Promoting Action on Research Implementation in Health Services (PARIHS)
framework (see Appendix K) was used to implement strategies to support the CLABSI
prevention bundle at a Midwest healthcare organization with an adult oncology unit. The
PARIHS framework was developed by Kitson, Harvey, and McCormack (1998) and is a
conceptual framework used to translate evidence into practice (Kitson et al., 2008). There are
three main parts of the framework: evidence, context, and facilitation. The framework focuses on
successful implementation being a function of the evidence, context, and facilitation of the
process. If the evidence, context, and facilitation are strong, then successful implementation is
likely to occur (Kitson et al., 1998; Kitson et al., 2008). This framework will be used to describe
the implementation process of a CLABSI bundle at the organization.
Evidence. Evidence includes research, clinical expertise, and patient choice (Kitson et
al., 1998). There is ample research available to support the implementation of a CLABSI
prevention bundle. Evidence-based CLABSI prevention toolkits support utilizing preventative
measures as a bundle (CDC, 2017b; Johns Hopkins University, 2009b; The Joint Commission,
2017a). In addition there are several research studies that support the use of the three
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interventions included in the proposed CLABSI prevention bundle. Multiple meta-analysis
supports the use of CHG bathing to prevent CLABSI (Kim et al., 2016; Frost et al., 2016, Shah
et al., 2016; Karki & Cheng, 2012; O’Horo et al., 2012).
A daily review of CVC and removal of unnecessary lines was also supported by the
literature (Marschall et al., 2014; Rutala et al., 2015; Marsteller et al., 2012). Changing
administration of blood products is evidence-based. Hermann and colleagues (1992) and Hanna
and Raad (2001) both note that the administration of blood is an independent risk factor for
CLABSI. O’Grady et al., (2011) supports changing administration sets within 24 hours after
receiving blood products. In addition, it is this organizations policy to change administration sets
(tubing and endcaps) immediately after finishing blood products.
This organization has identified the need for CLABSI prevention interventions due to the
increased number of CLABSI. Kitson and colleagues (1998) note that strong clinical expertise
includes consistency in staff views. Evidence is also supported by patient preference. Creating a
partnership with the patient can increase implementation success (Kitson et al., 1998).
Context. Context is the environment and setting in which a proposed change will be
implemented (Kitson et al., 1998). Context includes culture, leadership, and measurement. The
Burke-Litwin (1992) model was used to assess the organization for these qualities. High culture
includes patient centered care, a learning environment, continued education, and valuing people
(Kitson et al., 1998). The organization values patient centered care and utilized an
interprofessional team to provide evidence-based quality patient care. The culture is impacted by
continued efforts to decrease CLABSI rates and education about CVC care. The overall
organizational culture of the organization is well established and includes strong
interprofessional relationships.
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Strong leadership provides clear roles, effective teamwork, transparent leadership, and
strong organizational structure (Kitson et al., 1998). The leadership at the organization is clearly
defined. Individual roles are also clearly defined and people know to whom they report.
Measurement involves routine evaluation of internal measures, frequent auditing and
feedback, peer review, and the use of external measures (Kitson et al., 1998). The organization
frequently monitors CLABSI rates and the use of prevention efforts. During RN-to-RN report,
peer review has previously been implemented to evaluate the integrity of the central line
dressing. Leadership also reports CLABSI rates to employees monthly. A few measures have
been lacking, including how often RNs change and chart endcap changes after blood
administration, if there is prioritization of bathing patients with central lines, and if unnecessary
central lines are being removed. Measurements of practice improvements were addressed during
the CLABSI prevention bundle implementation in order to be successful and sustainable.
Facilitation. Facilitation is a technique used to make change easier for others. This can
include support to help people change attitudes, ways of thinking, and work flow to allow for
successful implementation (Kitson et al., 1998). Facilitation includes the characteristics, roles,
and styles of the organization and individual members. High levels of facilitation include
flexibility, consistency, presence, and support. The oncology unit at the organization possesses
many of these characteristics. There was a strong support for implementation of a CLABSI
prevention bundle to be implemented. Individuals and leadership at the organization were
flexible and transparent about change. Support for implementation of a CLABSI prevention
bundle was high at the organization.
Need and Feasibility Assessment of the Organization/Population
The Midwest healthcare organization with an oncology unit identified an elevated
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CLABSI rate and the need for CLABSI prevention interventions. The Burke and Litwin (1992)
model was utilized to conduct an organizational assessment. An organizational assessment is a
systematic process used to evaluate factors that affect performance of an organization (Rojas &
Laidlaw, 2016). It can also be thought of as an instrument to use when evaluating an organization
for issues and interventions to address the issues (Stone, 2015).
The purpose of the organizational assessment was to use the Burke-Litwin (1992) Model
of Organizational Performance and Change to analyze the state of the organization. Readiness
for a quality improvement project that will implement an intervention to prevent CLABSI was
also evaluated. Special attention was given to practices associated with prevention of CLABSI,
as the setting has identified a problem in this area.
The Burke and Litwin Model of Organizational Performance and Change is a causal
model. This means that each variable in the model affects every other variable. The model
originated in the 1960’s and is used in practice today, as it has content validity and internal
consistency reliability (Burke & Litwin, 1992; Stone, 2015). There are 12 organizational
variables that make up the model, each impacting another, which indicates an open-systems
principle (see Appendix G). The 12 variables are: external environment, mission and strategy,
leadership, organizational culture, structure, management practices, systems including policies
and procedures, work unit climate, tasks and skills, motivation, individual needs and values, and
individual and organizational performance (Burke & Litwin, 1992). All twelve areas of the
framework were analyzed during the organizational assessment and an analysis of assessment
data completed.
The assessment data available for the organization included de-identified data regarding
the occurrence of CLABSI. The data included a deep dive audit on CLABSI for patients with a
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documented occurrence. The data were evaluated to identify trends among those with an
occurrence of CLABSI. All 8 (100%) of the central lines were non-cuffed. Five out of 8 (62.5%)
patients had tunneled lines. Also, 37.5% (n=3) of patients had 3 lumens, 50% (n=4) had 2
lumens, and 12.5% (n=1) had 1 lumen on the central line. Each patient had a different provider in
interventional radiology place the central line. All of central line dressings had been documented
as changed in the last seven days and per standards, within 48 hours prior to the CLABSI. An
RN accessed 100% (n=8) of the central lines within 72 hours of the infection and all lines (n=8,
100%) were identified to be patent. In this sample, 87.50% (n=7/8) received blood through the
central line prior to the infection. However, 100% (n=7 of 7) of patients did not have their end
caps changed on their central line after receiving blood. Additionally, 85.71% (n=6 of 7) of
patients had not had the tubing or endcaps changed within the last 24 hours prior to the infection.
Further, 83.33% (n=1 of 6) of patients did not have the invasive line interdisciplinary plan of
care activated. An interdisciplinary plan of care is part of the EHR that assists the RN to
remember when central lines should be flushed and when endcaps and tubing should be changed.
Notable, 100% (n=8) of the patients were neutropenic. The audits inconsistently identified when
the unit assessed daily line need. Half (n=4, 50%) of the audits stated assessments occurred
during RN-to-RN hand over, while the other half (n=4, 50%) indicated the assessments occurred
during interdisciplinary rounds, huddles, or checkpoints.
BMT rounds occur daily and include the provider, physician assistant or nurse
practitioner, nutritionist, social workers, pharmacist, and the registered nurses (RN) caring for
the patient. Rounds were observed to identify if the provider discussed the central line, if the
central line was viewed, or if the RN brought up removing the central line. Several hours were
spent on the unit shadowing the manager, RNs, nurse technicians (NTs), providers, patients, and
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family members, to determine the flow of the unit and usual practices. An observation log of
daily practices was completed. The log included a discussion of central lines during bone
marrow transplant rounds. The log also included data on the number of RNs that evaluated a
patient central line during report each morning. Seven out of 9 (78%) patients evaluated with a
central line had an RN view the central line dressing during report during the student
observation. During observed rounds 8 BMT patients with central lines were evaluated. The
provider visualized the central line in 7 of the 8 (87.5%) patients. The provider asked if the
central line was painful in 6 of 8 (75%) cases. In 1 of 8 (12.5%) cases the provider asked the
patient when the last dressing change occurred. Of the 8 BMT patients, 3 (37.5%) were to be
discharged within the following 48 hours. Removal of the central line was not discussed in any
of the 8 (0%) cases. In addition, the RN did not bring up removal the central line to the provider.
The practice of frequently asking about when a central line can be removed in order to prevent
infection could be improved in practice.
De-identified data that tracked daily patient bathing was also obtained and evaluated. The
bath log data indicates that there is opportunity for improvement. The June 2017 daily audit for
bathing with chlorhexidine gluconate found that 50 to 100% of patients were bathed daily with
chlorhexidine gluconate, mean of 81.2% (standard deviation [SD] 14.6). The goal on BMT is to
have 100% of patients bathed daily with chlorhexidine gluconate to prevent infections.
In summary, this data revealed areas for improvement. All (n=8, 100%) of the CLABSI
occurred in neutropenic patients. Seven out of 8 (87.5%) of the CLABSI were present in patients
who had received a blood transfusion and who had not had their central line end caps changed as
required. The organization inconsistently noted when the unit conducted daily assessment of the
need for a central line in each patient. Further, some patients had more than 1 central line or
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multiple lumens, which may not be necessary. The data revealed that there is an opportunity for
CLABSI prevention techniques, particularly focused on assessing daily for central line need,
changing of the end caps after receiving blood products, and daily CHG bathing.
In order to ameliorate the identified areas of weakness of CLABSI prevention identified
in the organizational assessment, the key stakeholders need to have buy in and support a change.
The organization has key stakeholders that are involved with and affected by practice change.
One key stakeholder is the unit manager who sought to seek further CLABSI prevention
methods. Other key stakeholders include healthcare providers, healthcare staff, administrative
staff, and patients. The primary stakeholders are the patients, RNs, and providers. Patients are
key, as care would affect their health outcomes and length of stay. RNs are key, as their practice
and workflow could be altered. RNs care includes bathing, central line dressing and end cap
changes, and advocating for removing a central line when appropriate. Providers are key
decision makers regarding central line need and removal. Thus, all three are key stakeholders.
Even with stakeholder buy in, the feasibility of implementing a CLABSI improvement project
was further evaluated. This was done through the assessment of the organizations strengths and
weaknesses, discussed below.
A strengths-weaknesses-opportunities-threats (SWOT) analysis was created to assess the
organization before implementing a quality improvement project (see Appendix H). A SWOT
analysis is helpful to determine how an organization can be more efficient and effective.
Strengths are identified as internal attributes of the organization that could assist with attaining a
goal (Culp, Eastwood, Turner, Goodman, & Ricketts, 2016). Weaknesses are the internal
attributes that are harmful for achieving a goal. Opportunities are the external conditions that
help achieve the goal. Threats are the external conditions that may prevent the goal from being
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achieved (Culp et al., 2016).
The organizations SWOT analysis revealed that the unit has several strengths. The
organization focuses on collaborative coordinated care and the staff on the unit care about patient
outcomes. The staff including providers, nurses, and administration support process
improvements. The staff of the unit is supportive and open to an intervention that will support
practice change and improvement to decrease the occurrence of CLABSI. In the past, staff have
been supportive when other interventions were initiated to decrease CLABSI, such as daily
audits of central lines in RN-to-RN report and using saran cling wrap to cover the central line
before showering rather than using an aqua guard cover. The data show that the RNs on the unit
routinely wash their hands in and out of patient rooms in order to prevent infection. The data
evaluating RN hand washing has been 100% for the last year. This is a unit strength as hand
washing decreases CLABSI.
A weakness of the unit is the elevated CLABSI rates and high utilization of central
venous catheters. The unit also has a large number of inexperienced RNs less than a year since
graduation. In addition, the unit is undergoing numerous changes both, at the unit and system
level. The organization is implementing a new EHR system, which may take priority over the
quality improvement project. Another weakness is the lack of education provided to RNs in the
last year about CLABSI prevention. Due to other system changes, the annual competency about
CLABSI prevention and sterile dressing changes did not occur.
Opportunities for the BMT unit include the opportunity to decrease CLABSI infection
rates, improve quality indicators on the unit, decrease hospital length of stay, and decrease
expenditures through prevention of CLABSI. By improving the quality and outcomes of care,
and decreasing the cost of care the organization can move toward the goal of becoming a leader
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of healthcare by 2020. Opportunity for additional evidence-based interventions regarding
CLABSI prevention and educational opportunities for providers, RNs, and NTs presently exist.
The unit faced threats that include an intervention to prevent CLABSI not being a goal
due to the many changes that are presently occurring at the organization. Another threat to
CLABSI prevention is the potential that not all staff will buy in to the quality improvement
project. Lastly, research shows that the BMT population has an increased risk for CLABSI as
compared to adult ICU patients with central lines.
Project Plan
Purpose of Project
The purpose of the Doctor of Nursing Practice (DNP) scholarly project was to address a
gap in evidence-based practice of CLABSI prevention methods at an identified Midwest health
system with an adult oncology population. This was addressed by answering the following
clinical question. What are the best evidence-based CLABSI prevention interventions for CVC
maintenance that are feasible and sustainable for the organization?
Objectives of Project
•

Education to RN and NTs about the CLABSI prevention bundle began January 8th, 2018.

•

The prevention bundle focused on three intervention components:
o RNs will change and document endcaps in the EHR after blood administration.
o RNs will ask about the necessity of central lines during daily rounds and
encourage the removal of unnecessary central lines with the interdisciplinary
team, including the physician.
o RNs and NTs will prioritize and provide CHG bathing to patients with CVCs
daily.
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•

Measurement using evaluation tools began January 15th, 2018 to measure outcomes
related to quality and sustainability of the practice change (see Appendix M).

•

Dissemination of work to key stakeholders was completed on March 13th, 2018.

•

A sustainability plan was provided to the organization on March 13th, 2018.

Type of Project
This project was a quality improvement project that focused on translating evidencebased initiatives into practice. Quality improvement projects focus on improving healthcare
services and the health status of a targeted population (Health Resources and Services
Administration [HRSA], 2011). The purpose of this quality improvement project was to
implement at CLABSI prevention bundle to decrease the rate of CLABSI. In order for the
organization to see improvement in quality outcomes, the current CLABSI prevention process
needed to improve.
Setting and Resources Utilization
The setting for the DNP project was at a Midwest healthcare system that has an adult
oncology setting. The implementation took place at the adult oncology setting. The resources for
this project included access to the EHR. The EHR was used to collect and analyze data. The time
of hospital personnel, including clinicians, RNs, and NTs were another resource used. RNs and
NTs attended educational meetings and also were an important part of implementation. In
addition, the assistance of a statistician was utilized to assist with data analysis.
Design for the Evidence-Based Initiative
The PARIHS framework (Kitson et al., 1998) was used to guide the quality improvement
implementation of a CLABSI prevention bundle at a Midwest health system with an adult
oncology unit.
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o Evidence: Research evidence from CLABSI prevention toolkits and high level research
on CHG bathing, prompt central line removal, and changing administration sets after
receiving blood products all supported the implementation of a CLABSI prevention
bundle. Interprofessional partnerships and partnerships between healthcare personnel and
patients provided evidence for the implementation.
o Context: The culture of the organization valued quality improvement and evidence-based
patient centered care. The implementation of a CLABSI improvement project was
identified by the organization to improve patient outcomes. An organizational assessment
of the healthcare center identified gaps in current practice, which further supported the
need of the implementation of a CLABSI care bundle. The context was used to determine
the measureable data, analysis, and provide feedback to stakeholders. Moreover, context
was able to provide a cultural perspective for development of a sustainability plan.
o Facilitation: Facilitation includes the support within the organization needed to make
change. Individuals and leadership at the organization were flexible and transparent about
change. Members of the organization were supported as they went through change in
workflow. The DNP student conducted site visits several times a week to observe daily
patient rounds, preform audits in the EHR to determine compliance with daily CHG
bathing and documentation of changing endcaps after administration of blood.
Facilitation also included meetings with healthcare staff and key stakeholders about the
project.
Participants/Sampling and Recruitment Strategies
This project involved adult oncology bone marrow transplant patients who had CVCs in
place during the time of project implementation. Staff members, RNs, NTs, and clinicians
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involved in direct patient care and daily patient rounds played a primary role in the implantation
of the CLABSI bundle. The EHR was utilized to analyze data pertaining to CHG bathing and
changing of administration sets after receiving blood. Recruitment for this project was not
necessary.
Measurement: Sources of Data and Tools
The DNP student collected data during the implementation of the quality improvement
project (see Appendix M). The data collected was used to determine the effectiveness of the
CLABSI prevention bundle implementation. The organization granted the DNP student access to
daily patient rounds, bimonthly staff meetings, and EHR access. Access to de-identified deep
dive CLABSI audits were also provided by the manager.
The student developed a pre- and post- educational quiz (see Appendix L) that focused on
CLABSI prevention. The quiz was given to RNs and NTs on the oncology unit. The pre-quiz and
post-quiz results were evaluated to determine the effectiveness of education provided about
CLABSI prevention.
The student also collected data observed in daily rounds about RNs asking if unnecessary
CVC can be removed, audited EHR charting to determine if endcaps were changed after blood
administration, and audited EHR charting to determine if patients with central lines were bathed
daily in CHG. The data was then placed in spreadsheets created by the DNP Student (see
Appendix M) and analyzed. Patient information was de-identified in collection spreadsheets. The
number of CLABSI during the intervention was also tracked as this is usually done by the
organization. The number of CLABSI during the implementation was compared to the number of
CLABSI pre intervention.
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Steps and Timeline for Implementation of Project
The Implementation of this DNP project included:
o Providing education to RNs and NTs about CLABSI and CLABSI prevention.
Educational meetings can help change professional behavior and also improve patient
outcomes (Forsetlund et al., 2009). The rationale for the implementation for a CLABSI
prevention bundle was explained in 10-15 minute sessions during a daily meeting at the
organization which RNs and NTs are already required to attend (Appendix N & O).
Along with in person education, an educational email was sent to RNs, NTs and
providers involved in the CLABSI bundle implementation (see Appendix N & O). Powel
and colleagues (2015) note that using electronic education materials is a recognized
evidence-based implementation strategy. The pre-quiz was given before education,
starting January 8th. The post-quiz was given to staff after completing education, ending
on January 15th.
o A CLABSI prevention flyer was also posted on two notice boards on the unit on January
8th to help remind staff about the prevention bundle (see Appendix T).
o This implementation also involved workflow change on the oncology unit. RNs had to be
engaged and remember to ask about removing unnecessary CVC during daily patient
rounds. RNs and NTs experienced workflow change as they prioritized CHG bathing to
patients with CVC. Implementation began January 15th and data collection took place
until February 15th.
o The implementation included daily auditing and feedback. The use of audit and feedback
allows for the monitoring, evaluation, and modification of behavior (Powel et al., 2015).
Feedback to RNs during daily rounds was provided in the moment to the RN. Feedback
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after auditing charting in EHR was provided via email to the RN or NT and the manager
of the unit. Implementation began January 15th and data collection took place until
February 15th.
o Ongoing training to RNs and NTs was provided. Powell et al., (2015) notes that ongoing
training is an evidence-based implementation strategy. In the moment feedback and
strategies to increase performance will RNs and NTs was discussed. Implementation will
began January 15th and data collection took place until February 15th.
o The DNP student and a statistician analyzed all data. Data was summarized for the
manager of the unit by March 13th.
o Findings were disseminated to key stakeholders on March 13th.
o A sustainability plan for the CLABSI prevention bundle was created on February 19th and
presented to the key stakeholders on March 13th.
o The final CLABSI bundle was defended at Grand Valley State University on April, 2nd.
o The Implementation timeline is shown in (Appendix P).
Project Evaluation Plan
This quality improvement project was evaluated by collecting outcome data (listed
below) to examine overall quality improvement (decreased number of CLABSI). The DNP
student collected and analyzed data, along with a statistician, to evaluate the effectiveness of
each intervention. The DNP student was responsible for all data collection.
The aim of the project was to prevent CLABSI. Outcomes were met as there were
decreased CLABSI and also the following objectives are met.
o RNs will change and document endcaps in the EHR after blood administration. This will
be evaluated in the EHR (see Appendix M).
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o RNs will ask about the necessity of central lines during daily rounds and encourage the
removal of unnecessary central lines with the interdisciplinary team, including the
physician. This will be evaluated based on observation data collected during rounds (see
Appendix M).
o EHR data will be collected to evaluate if RNs and NTs prioritize and provide CHG
bathing to patients with CVCs daily (see Appendix M).
The DNP student used the spreadsheets in (see Appendix M) to collect and analyze the
data. Dissemination of the evaluation data was presented to stakeholders. Charts, graphs, and
percentages of each monitored outcome and all other data, including pre and post quiz results
were presented.
Ethics and Human Subjects Protection
The DNP project was submitted to the Grand Valley State University Human Research
Review Committee for institutional board determination (IRB) and was determined to be nonresearch (see Appendix Q). The organization at which CLABSI prevention bundle was
implemented also provided IRB determination of non-research (see Appendix R). Neither
organization required a formal presentation for the ethics review board. All data analyzed was
de-identified of any patient sensitive information.
Budget
The DNP project of implementing a CLABSI prevention bundle included an estimated
budget (see Appendix S). The DNP student donated many of the costs in this project. The DNP
student donated immersion hours (20) towards educating staff about CLABSI and CLABSI
prevention. This included sending out an educational flyer and also meeting with staff during
daily team meetings (10 minutes for 7 meetings) on January 8-14th. The DNP student donated
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immersion hours (2) for the creation of a pre-post quiz. The DNP student volunteered immersion
hours (4) on 17 of the 31 intervention days (68 hours total) to observe rounds and collect data
from the EHR. The estimated cost for a charge RN with 4 years of experience and an hourly rate
estimate is $31 per hours (Pay Scale, 2017a). The total cost for the DNP student managing the
project is $2,790.
Other resources included time of staff members to make the implementation attainable.
The oncology unit manager attended several meetings and answered emails (10 hours). The
average nurse manager hourly wage is $35.77 for a total donated cost of $357.70 (Pay Scale,
2017b). Moreover, education to each RN was provided in approximately 10 minutes. Using a
RN hourly rate of $29 for 26 RNs this would cost the organization $125.66. There are 14 NTs
that also received education. The estimated NT hourly wage is $12 (Pay Scale, 2017c). Ten
minutes of education for each NT resulted in $28. Providers including the following, Nurse
Practitioner (NP), Physicians Assistant (PA), and Physicians also read the educational email
regarding the CLABSI bundle implementation. This took approximately15 minutes to read. The
estimated hourly wage of the NP is $50, PA $50, and Physician $100 (Pay Scale 2017d; Pay
Scale, 2017e, Pay Scale 2017f). There are 3 physicians, one NP, and one PA for a total cost of
$70. After data collection, a GVSU student research assistant was utilized to help with data
analysis. An estimated 10 hours were spent at an hourly wage of $10 for a total cost of $100.
Taking into consideration the potential cost savings of the project is important as well. If
the DNP project were able to prevent one CLABSI, it would save the organization an estimated
$3,700 to $39,000 per CLABSI case (Marschall et al., 2014; Crnich, 2010). An estimated cost
savings was conducted at the completion of the data collection. The CLABSI prevention bundle
was successful, and there was a cost savings for the organization.
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Results
Pre-Post CLABSI Bundle Education Quiz
Thirty-two of 40 (80%) pre-education quiz (see Appendix L) were submitted to the DNP
student. Completion of the pre-education quiz was voluntary. This included 18 RNs, 7 NTs, and
7 NT or RN who did not identify with the role. The mean on the pre-quiz was 76.6% (SD 24.1).
Individual question review demonstrated, all takers (N=40, 100%) had question 1 correct. Four
(10%) individuals missed question 2. Twelve (30%) individuals answered question 3 incorrectly;
and 10 (25%) answered question 4 incorrectly. After evaluation of pre-quiz results, the DNP
student focused education sessions on question 3 and 4 content. Consequently, education focused
on CHG bathing prioritization and asking about central line necessity during daily rounds. The
DNP student was not surprised that multiple participants incorrectly answered question 4, as
daily discussion of central line necessity was not currently done on the unit.
The DNP student collected the post-quiz quiz and evaluated the data after education
regarding the CLABSI prevention bundle. All RN’s and NT’s were provided education.
Completion of the post-education quiz was voluntary. Thirty of the 40 (75%) participants
completed the post-education quiz. This included 15 RNs (50%) , 8 NTs (27%), and 7 (23%)
who did not identify the role. The mean on the post-quiz was 95.8% (SD 11.5). After review, it
was noted one participant had question 1 incorrect, two people had question 2 incorrect, one
person had question 3 incorrect, and one person had question 4 incorrect. The mean score
improved 19.2% (p-Value 0.0015) from pre- to post-quiz. The improved quiz score indicates that
CLABSI prevention education was successful.
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End Cap Change Audits Following Blood Administration
During the one month data collection period, 18 blood products were administered to
patients with CVC lines. In the EHR audit, it was noted that RNs changed the central line endcap
of the central line in 16 instances (88.9%) and did not in 2 cases (11.1%) (see Appendix U).
Based on data prior to implementation, seven patients received blood and none (0%) had the
endcap changed following the blood administration. The prior data was from CLABSI cases that
received blood during September 2016-May 2017. Overall, a 89.0% (p-Value= <0.0001)
increase in compliance with end cap change occurred.
The DNP student provided email feedback to the two RNs who did not chart that the
endcap was changed. The manager on the unit was copied on the email. It is unknown if the
endcaps were changed and the RN’s simply forgot charting. No barriers were identified during
the implementation to changing endcaps after blood products.
Audit of CVC Line Necessity
Observation of daily rounds to determine if RNs asked about the necessity of CVC and
removal of unnecessary lines was conducted in 102 instances. RNs asked about the necessity of
CVC in 93 of 102 instances (91.3%) and did not in 9 (8.8%) of the cases (see Appendix V).
During the month long implementation, two CVCs were removed as a result of the daily line
audit. During the implementation period, the DNP student encouraged 5 additional CVC to
removed, but was not successful. Prior to implementation, removal of the central line was not
discussed in any of the 8 (0%) cases that were evaluated. Therefore, a 91.3% (p-Value <0.0001)
increase is noted in discussion of central line necessity during daily rounds.
In the moment face-to-face feedback was provided to RNs who did not ask about line
necessity in 9 instances. Barriers to asking included RNs not being able to come to rounds due to
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being busy with other patients at the time. The primary barrier for line removal identified was
provider preference and limited time before patient discharge. Providers would often state during
rounds that they would like to keep the CVC due to patient need, such as electrolyte replacement
or low platelet counts. However, the DNP student did point out that electrolyte replacement
could be done through a peripheral IV. In addition, due to lack of planning, often the line
removal was not discussed until just prior to discharge, leading to problems with coordinating
care. Patients with CVCs that needed to be surgically removed could not be scheduled prior to
discharge. In these cases, the DNP student encouraged line removal as soon as possible.
CHG Bathing Audits
The DNP student evaluated CHG bathing in two ways. The first was a measure based on
the DNP student standard of either “yes” or “no” for, was the patient bathed daily in CHG. This
data was not directly compared to the pre-implementation data, as the unit measured bathing in a
different manner. The unit standard/measure of bathing counted “yes” for bathed with CHG even
if CHG was not charted, or if a patient refused bathing twice in a day; and a “no” with no bath at
all or only being charted as refused once.
DNP standard measure.
CHG bathing included 115 audits from the EHR of patients with CVC on the unit during
the implementation timeframe. The same patient may have been audited several times if they
were on the unit during the implementation phase. Data were missing in 16 audits, due to the
patient being discharged or transferred to a different unit. It was noted that 63.6% (n=63) patients
had CHG bathing while 36.4% (n=36) did not (see Appendix W).
Unit standard measure.
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The same number of audit and missing data were used as above. It was noted that 83.8%
(n= 83) patients had CHG bathing while 16.2% (n= 16) did not (see Appendix X). When the data
was compared to the month of June 2017 data, it was noted that the mean bathed daily were
81.2%. Implementation of the CLABSI bundle increased daily CHG bathing rates by 2.6% (pValue >0.05).
Feedback on charting was provided via email to RNs and NTs with the manager copied
in the email. Barriers to implementation included lack of education for staff working on the unit
from other units as they were unaware of the importance of CHG bathing and proper
documentation of CHG bathing in the EHR. Moreover, barriers also included lack of knowledge
to new RNs on orientation about charting properly.
Overall CLABSI rates.
The CLABSI prevention bundle was implemented over the time period of January 15th to
February 15th 2018. During this time, no CLABSI were noted in the adult oncology BMT
population. In December and November 2017, just prior to implementation of the bundle, a
CLABSI occurred each month. The organizational assessment revealed eight CLABSI in the
prior year. Based on the limited implementation period, it appears that the CLABSI prevention
bundle prevented the occurrence of CLABSI.
Discussion
There were no CLABSI identified during the implementation period. All measures
improved, when compared to available data prior to implementation. The knowledge increase
regarding CLABSI prevention increased (19.2%). The CLABSI prevention 3-part bundle
prevented infections. End cap change audits improved by (89%) and daily rounds audits results
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increased by (91.3%). The student discovered that during follow up for end cap audits, the
practice had been completed, but the RN’s forgot to complete the documentation in the EHR.
The DNP student found the unit measured CHG bathing in a different manner than
planned. Consequently, the CHG data was measured two ways. The DNP standard measure
noted that (63.6%) patients had CHG bathing. The unit standard measure noted (83.8%) patients
had CHG bathing and was compared to June 2017 CHG bathing (81.2%) for a (2.6%) increase.
Of the three interventions of the bundle, CHG bathing saw the least improvement. Often, patients
would refuse to be bathed daily and would chose every other day or RN/NTs would chart
shower/bath the patient and not remember to also chart CHG. Further education for patients
regarding the importance of CHG may increase daily CHG bathing rates.
During the project implementation, there was a surprise visit by the Joint Commision.
The staff were asked, “what are you most proud of?” Several staff members brought up the
CLABSI bundle. This really showed the staff commitment to the CLABSI prevention bundle and
is a indicator for sustainability.
Limitations
This project had a short implementation period and small sample sizes. The sample size
made it challenging to evaluate statistical difference in each bundle component. Another
limitation was the small amount of data prior to the project. For example, the sample size of
patients before the implementation phase was 7 for measuring endcap change compared to 18
during the implementation period. This was similar for daily rounds, 8 pre and 102 post
assessment data points. In addition, another limitation is that the measures used have no
reliability or validity.
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The DNP student or another RN brought up line necessity or removal each time during
rounds. The providers did not take the initiative during the rounds that were observed by the
DNP student. As the one month implementation period went on, the provider buy in increased. A
new Attending who was hired during the project period was a stong advocate for removing
unnecessary lines. The DNP student would recommend that the providers of the organization
create a policy to follow for when CVC should be removed. This would create congruency in
practice between all of the provders on the teeam providing care for this patient population.
A new EHR charting system was implemented a month before the project
implementation began. This created stress for staff members and many of them struggled to find
the proper charting area for CHG despite a handout was provided to every staff member. As
noted, the CLABSI bundle had several limitations, however it was overall effective at preventing
CLABSI.
Stakeholder Support and Sustainability
The manager of the adult oncology unit at the organization brought this DNP project to
the DNP student. This key stakeholder support for a CLABSI prevention intervention was crucial
for successful implementation of the CLABSI prevention bundle. Because of this stong support,
the DNP project will be sustainable.
Sustainability of the DNP project could be achieved, as the CLABSI prevention bundle
prevented infections, making it likely to remain in place. The manager is committed to using the
bundle, and will monitor the effectiveness of the CLABSI bundle. In addition, a new policy was
created for the manager based on the present policy regarding CVC maintenance in the
organization (Appendix Y). The manager of the unit reviewed the proposed draft policy. The
organization has a policy titled, “Central Venous Catheter: Insertion, Maintenance, Utilization,
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and Removal-Adult.” This policy has 9 sections. The policy does not discuss any of the items in
the CLABSI bundle. The organization does have a policy for administering blood products that
already discusses changing the endcap after blood administration. No modification of this policy
is recommended.
It is suggested that an additional section be added to the central venous catheter policy
titled “CLABSI prevention during the maintenance period.” The addition of this section to the
policy would create a foundation for CLABSI prevention and create sustainability to the
CLABSI bundle (Appendix Y). This would also provide RNs a reliable source to reference
regarding CLABSI prevention. The manager of the unit agreed to provide the draft policy to the
CNS at the organization who works on the policy. This will hopefully lead to systemwide
implementation of the CLABSI prevention bundle.
Implications for Practice
This DNP project had multiple practice implications. CLABSI can be prevented. By
preventing CLABSI, patient quality outcomes are improved and healthcare costs are decreased.
Evidence supports using a CLABSI prevention bundle and suggests the implementation will
decrease the rate of or prevent CLABSI.
Each component of the CLABSI bundle proved to be a success. The bundle could
positively impact CLABSI rates on the unit in the future. When evaluating the implementation of
the CLASBSI bundle and the implications for practice, it is important to include the thought
process of polarity management. During the process the ideas of complacency versus change
were apparent. Providers were often reluctant to change practice and lean toward their current
method of practice, as it is more comfortable and easier. However, with repeated discussions and
encouragement, change did occur. Providers were eventually willing to remove lines when
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discussed during daily rounds. The implementation of the CLABSI bundle was intended to
decrease the number of CLABSI. The idea of CLABSI prevention using the CLABSI prevention
bundle on the unit was not a problem with a simple fix, but rather a polarity that must be
continuously managed.
Reflections on Doctorate of Nursing Practice Essentials
The American Association of Colleges of Nursing (AACN) requires that all DNP
students meet the eight essential competencies in order to graduate (AACN, 2006). The eight
essentials provide a foundation for the nurse practitioner in any role. The eight essentials were
met throughout the development, implementation, and dissemination of this CLABSI prevention
project.
Scientific Underpinnings for Practice
The scientific foundation of nursing is ever changing and based on evidence across all
sciences. The use of conceptual frameworks and theories guide doctoral nursing practice
(AACN, 2006). Throughout the CLABSI prevention quality improvement project, science-based
theories were used to evaluate health care delivery. New workflow approaches were developed
as evidence-based practices were implemented to prevent CLABSI. Nursing theory and theory
from other disciplines were utilized during the project. The CDC’s ID Framework was utilized to
guide the disease (CLABSI) prevention process (CDC, 2011). The PARIHS Framework guided
the implementation of the CLABSI prevention bundle, with a focus on evidence, context, and
facilitation (Kitson et al., 1998). The CLABSI prevention bundle was created based on evidence,
and implemented using theoretical frameworks from different scientific practice areas.
Organizational and Systems Leadership
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Leadership is essential to improve patient safety and healthcare outcomes. The doctoral
nurse should be able to conceptualize health care delivery models based on nursing science that
improve quality of care (AACN, 2006). The student demonstrated organizational and systems
leadership by first meeting with the organizational leader and conducting an organizational needs
assessment. This allowed for the student to develop a project that met the organizations needs
and also create a project that could be completed in a limited timeframe. This quality
improvement project evaluated the current care delivery approach for CALBSI prevention at the
organization. Leadership and communication skills were used throughout the project.
Communication with the manager, staff members, and providers occurred frequently and through
various methods including face-to-face, email, and flyers. The unique needs of the unit, key
stakeholders, and patents were considered during project development and implementation. The
student demonstrated ethical and cultural sensitivity during the project. The project was
submitted to the organization and university HRRC committee and deemed non-research.
Clinical Scholarship and Analytical Methods
The AACN (2006) notes that that the DNP can translate evidence into practice, evaluate
practice, and improve healthcare outcomes. This student used analytic methods when reviewing
literature on CLABSI prevention bundles to determine the best evidence based interventions.
The project included the design and implementation process of the CLABSI bundle and
evaluation of effectiveness. The quality improvement project was designed to promote safe
patient centered care. Information technology was used to collect EHR data about CHG bathing
and charting of central line end caps. This information was then analyzed to determine patterns
of behavior, outcomes, and CLABSI trends. Statistics were used to evaluate the data. Results
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were disseminated from this evidence-based practice quality improvement project in order
improve patient health outcomes.
Information Systems Technology
The use of information technology improves patient outcomes and improves healthcare
outcomes (AACN, 2006). The student used screenshots of the EHR to provide examples of
proper charting as part of the CLABSI prevention bundle education. Emails were used as a
primary source of communication between the student and organization members. The student
used an EHR system to monitor the quality improvement project. Data extraction from chart
audits was completed to determine if various parts of the CLABSI prevention bundle were met.
Microsoft Excel was used to analyze the data collected during the project.
Advocacy for Health Care Policy
Engagement in health care policy is an expectation of the DNP student. Policy influences
many dynamics of healthcare and DNP’s are prepared to influence, design, and implement policy
(AANC, 2006). This project included the student analyzing the organizations current policy on
central venous catheters and CLABSI prevention. The student was also able to write a proposed
policy for the organization to utilize for CLABSI prevention utilizing the CLABSI prevention
bundle as a guide. This project did not include policy change at a state, federal, or international
level.
Interprofessional Collaboration
Providing excellent healthcare includes interprofessional collaboration. The DNP
graduate is a leader and has the capability to facilitate interprofessional collaboration of the
healthcare team (AACN, 2006). The DNP student participated in collaboration and effective
communication with key stakeholders from the organization, providers, staff members, and
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faculty members during the development and implementation of the project. Collaboration with
team members was integral to success of the project. The student worked closely with staff
members to provide CLABSI prevention education and to answer questions during the project
implementation.
Clinical Prevention Population Health
The DNP has a foundation in health promotion and disease prevention. This knowledge
basis includes the ability to analyze data on public health (AACN, 2006). This project focused on
prevention of central line infections in an adult oncology population. The student analyzed
specific unit data related to CLABSI and attempted to improve the health status of patients
through the implementation for a CLABSI prevention bundle. The environmental, cultural, and
occupational health needs of the organization were taken into consideration when developing the
quality improvement project.
Advanced Nursing Practice
The DNP graduate has knowledge of one advanced role in nursing practice (AACN,
2006). This project focused on the adult-older adult gerontology population. The student
demonstrated advanced nursing practice by facilitating the CLABSI prevention bundle quality
improvement project. The student acted as a leader and consultant during the implementation
period. Partnerships were developed with other professionals that allowed optimal outcomes.
The student encouraged other RNs to engage in the project in order to provide evidence-based
patient centered care. The student acted as a change agent in the organization and created an
opportunity for improvement in healthcare outcomes.
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Dissemination of Outcomes
Dissemination of this CLABSI care bundle first occurred with the stakeholders of the
adult oncology unit at the Midwest healthcare system on March 13th, 2018. The final product of
this quality improvement was presented at Grand Valley State Univeristy in front of the DNP’s
student project team and other members of the college who choose to attend the presentation on
April 2nd, 2018. The final draft of the scholarly project paper was uploaded to ScholarWorks©.
Additionally, the DNP student could disseminate findings by publishing the results of this DNP
Project about implementing a CLABSI prevention bundle.
Conclusion
A Midwest healthcare organization with a focus on adult oncology patients sought help to
reduce the number of CLABSI. An organizational assessment revealed that 8 CLABSI had
occurred in the last year. A literature review of CLABSI prevention toolkits was conducted to
identify the best evidence based interventions to use at the organization. Two theoretical
frameworks were utilized to implement a three-part CLABSI prevention bundle. The three part
bundle focused on (a) RNs changing and documenting endcaps in the EHR after blood
administration (b) RNs asking about the necessity of central lines during daily rounds and
encouraging the removal of unnecessary lines with the interdisciplinary team and (c) RNs and
NTs prioritizing and providing CHG bathing to patients with CVCs daily. Implementation took
place for one month. Results revealed an increase in all three CLABSI prevention bundle
components. No CLABSI were noted during the implementation phase. This type of CLABSI
prevention bundle is important as nursing staff have the opportunity to prevent infection and
decrease the cost of care for patients with a central venous catheter. By preventing just one
CLABSI, $22,611 was saved and potentially a life.
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APPENDICES
Appendix A
CDC Criteria for CLABSI
The central line was in place for at least 2 calendar days on the date of event, with day
of device placement being day 1 and the line was also in place on the date of event or
the day before.
If central line was in place for at least 2 calendar days and then removed, the date of
event of the laboratory-confirmed bloodstream infection must be the day of
discontinuation or the next day to be a CLABSI.
Figure 1. CDC Criteria for CLABSI
CDC. (2017a). Bloodstream infection event (central line-associated bloodstream infection and
non-central line-associated bloodstream infection). Retrieved from:
https://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf

68

Appendix B
CLABSI Prevention Toolkits Selection Process
The Joint
Commission

CDC

Johns Hopkins

AHRQ


The Joint Commission

CDC

Figure 2. CLABSI Prevention Toolkits Selection Process.

Johns Hopkins
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Appendix C
Toolkit Source and Recommended Interventions to Prevent CLABSI in the Maintenance Period

Toolkit
The Joint Commission

•
•
•

•
•
•
•
•
•

Center for Disease Control and Infection

•
•
•
•
•
•

Recommended Interventions
Catheter hubs, injection ports, and
connectors should be disinfected
prior to use.
Closed catheter systems are
associated with fewer infections
Chlorhexidine with alcohol or 70%
alcohol are recommended for use
when disinfecting catheter hubs, in
addition to scrubbing for 15
seconds.
All patients in the ICU over two
months of age be bathed daily with
2% chlorhexidine.
Change the administration set
immediately after blood products.
Use aseptic technique when
accessing the catheter.
Perform daily review of line
necessity with prompt removal of
unnecessary CVCs.
Perform hand hygiene.
Change central line dressings every
7 days.
Comply with hand hygiene
requirements
Bathe ICU patients over 2 months
of age with a chlorhexidine
preparation daily.
Scrub the access port or hub with
friction before accessing with
appropriate antiseptic.
Use only sterile devices to access
catheters
Preform dressing change with
sterile technique.
Change gauze dressings every two
days and semipermeable dressings
every seven days.
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•

•
•
•
•

Johns Hopkins University

•

Adults 18 years of age or older
should use chlorhexidine
impregnated dressing with FDA
clear label that includes indication
for central line.
Change continuous administration
sets no more frequently than every
4 days, but at least every 7 days.
If blood products or fat emulsions
given change administration set
every 24 hours.
If propofol administered change
tubing every 6-12 hours or when
vial is changed.
Preform a daily audit to determine
if the central line is needed and to
remove unnecessary central lines.
Ask daily if the central line can be
removed

Figure 3. Toolkit Source and Recommended Interventions to Prevent CLABSI in Maintenance
Period
CDC. (2017b). Checklist for prevention of central line associated blood stream infections.
Retrieved from: https://www.cdc.gov/hai/pdfs/bsi/checklist-for-CLABSI.pdf
Johns Hopkins University Quality and Safety Research Group. (2009b). CLABSI Toolkit.
Retrieved from:
http://www.hopkinsmedicine.org/armstrong_institute/improvement_projects/stop_bsi/cla
bsi_toolkit.html
The Joint Commission. (2017a). CLABSI toolkit and monograph. Retrieved from:
https://www.jointcommission.org/topics/clabsi_toolkit.aspx
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Appendix D
Johns Hopkins University Appendices A-M
Location
Appendix A

Appendix B

Appendix C
Appendix D
Appendix E
Appendix F

Appendix G

Appendix H
Appendix HA
Appendix HB
Appendix HC
Appendix HD-HJ
Appendix HK
Appendix HL
Appendix I

Appendix J

Tools, Checklists, and References
Article by Pronovost and colleagues
(2016) about interventions to decrease
CLABSI in the ICU.
A CLABSI fact sheet that provides of the
result of CLABSI financially and the five
interventions identified to reduce the risk
of CLABSI: hand hygiene, chlorhexidine
skin prep, full-barrier precautions during
insertion, avoiding the femoral vein, and
removing unnecessary lines.
Provides definitions of healthcare
associated infections.
A link to the National Healthcare Safety
Network Manual.
A PowerPoint presentation about the
guidelines for preventing CLABSI.
A vascular access device quiz, which can
be utilized after implementing the
PowerPoint from Appendix E.
Article by Marschall and colleagues
(2008) about strategies to prevent
CLABSI in hospitals.
The Johns Hopkins Vascular Access
Device Policy.
A vascular access device scope of
practice for nursing.
Catheter choice diagram.
Johns Hopkins Health System Central
Line Insertion Care Team Checklist.
Discusses how to care for a patient with
different line types.
Discussed the care for a patient receiving
parenteral or enteral nutrition.
Discusses de-accessing a port.
Includes the Johns Hopkins central
venous access device dressing change
policy.
Includes a central line cart inventory list
with items that should be in the insertion
cart.
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Appendix K

Appendix L
Appendix M

A daily goals checklist for nursing. This
checklist will be discussed in detail in
prevention maintenance methods.
A central line insertion checklist.
Annotated bibliography

Figure 4. Johns Hopkins University Appendices A-M
Johns Hopkins University Quality and Safety Research Group. (2009b). CLABSI Toolkit.
Retrieved from:
http://www.hopkinsmedicine.org/armstrong_institute/improvement_projects/stop_bsi/cla
bsi_toolkit.html
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Appendix E
The Joint Commission: Daily Central Line Maintenance Checklist-Template

The Joint Commission. (2017e). Daily central line maintenance checklist-template. Retrieved
from: http://www.jointcommission.org/assets/1/6/CLABSI_Toolkit_Tool_323_Daily_Central_Line_Maintenance_Checklist_-_Template.pdf
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Appendix F
CDC: Checklist for Prevention of Central Line Associated Bloodstream Infections

CDC. (2017b). Checklist for prevention of central line associated blood stream infections.
Retrieved from: https://www.cdc.gov/hai/pdfs/bsi/checklist-for-CLABSI.pdf
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Appendix G
Burke and Litwin: A Causal Model of Organizational Performance and Change

Figure 5. A model of organizational performance and change. Reprinted from “A Causal Model
of Organizational Performance and Change,” by W. W. Burke and G. H. Litwin, 1992, Journal
of Management, 18, 528. Copyright 1992 by Southern Management Association.
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Appendix H
SWOT Analysis
•
•
•
•

Strengths
Focus on collaborative and
coordinated care
Support for CLABSI quality
improvement from key
stakeholders
Previous engagement in past
attempts to reduce CLABSI
RNs engage in frequent hand
washing to prevent infection.

•
•
•
•
•
•

•
•
•
•

Opportunities
Improving quality and outcomes of •
care by implementing evidencebased practice
Potential to decrease cost of care
•
Potential to decrease number of
CLABSI
Improve education provided to
•
RNs about CLABSI prevention
•

•

Weaknesses
New unit undergoing many changes
both at the unit and system level
New EHR implementation
Many RNs are new with less than
one year of experience
High utilization of central venous
catheters
Lack of RN education in the last year
about CLABSI prevention
Employee burnout, retention, and
shortage

Threats
Funding may not be available for
additional CLABSI prevention
interventions
CLABSI prevention interventions
may not be at the forefront with so
many other changes system wide
presently occurring
Potential for lack of “buy in” from
staff members
BMT populations have high
incidence of CLABSI

* Bolded areas focused on during project implementation

Figure 6. SWOT Analysis of BMT Unit
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Appendix I
Johns Hopkins University Daily Goals Checklist
Daily Goals
Date ____/____/____

Room Number _____

PM shift (7pm)
**Note Changes from AM**

Safety

AM shift (7am)
What needs to be done for patient to be
discharged from the ICU?
▪ Patient’s greatest safety risk?
▪ How can we decrease risk?
What events or deviations need to be reported?
ICUSRS issues?
Pain Mgt / Sedation
(held to follow commands?)
Cardiac
Review EKGs
Volume status
Net goal for midnight
▪
▪

Pulmonary:
Ventilator: (vent bundle: HOB elevated),
Weaning)

Patient Care

SIRS/Infection/Sepsis Evaluation
SIRS Criteria
 Temp > 38° C or  < 36 ° C
 HR > 90 BPM
 RR > 20 b/min or  PaCO2 < 32 torr
 WBC > 12K  < 4K or  > 10% bands
Can catheters/tubes be removed?
GI / Nutrition / Bowel regimen
(TPN line, NDT, PEG needed?)
Is this patient receiving DVT/PUD
prophylaxis?
Anticipated LOS > 2 days: KCl Sliding Scale

To Do:

Can any meds be discontinued, converted to
PO, adjusted?

Pain goal ____/ 10 w/
HR Goal_______  at goal
   ß Block_________
 Net even  Net positive
 Net neg:____ w/_______
 Pt determined
 OOB  Pulm toilet  Ambulation
 Maintain current support
 Wean as tol
 Mechanics q am
FIO2 <_____ PEEP____  PS / Trach trial___h
 no current SIRS / Sepsis issues
 Known infection:
 PAN Cx  Bld x2  Urine  Sputum
 Other
 ABx changes; D/C
 Sepsis Bundle
Y N
 TPN

 TF  NPO

DVT:  Hep q8 / q12 / gtt
 TEDS/SCDs
 LMWH

PUD:  PPI
 H2B

 KCl
 N/A
 D/C:

 PO:

 Renal:

 Liver:

Tests / Procedures today

 N/A

Scheduled labs

 N/A

AM lab needed
CXR?

 AG Levels:

 CMP  BMP  H8  Coags  ABG
 Lactate  Core 4
 CXR
Wed:  Transferrin  Iron  Prealb 24h urine

Consultations

YN

Disposition
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Is the primary service up-to-date?

Y N

▪
▪

Y N

Has the family been updated?
Social issues addressed
(LT care, palliative care)

Protocols available if bolded
For WICU only: ICU status

Y  N  N/A

IMC status: vitals q___ Fellow/Attg Initials: ____________

Figure 7. Johns Hopkins University Quality and Safety Research Group. (2009b). CLABSI
Toolkit. Retrieved from:
http://www.hopkinsmedicine.org/armstrong_institute/improvement_projects/stop_bsi/cla
bsi_toolkit.html
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Appendix J
CDC ID Framework

Element 1.
Strengthen public
health
fundamentals,
including
infectious disease
surveillance,
laboratory
deterction, and
epidemiologic,
investigation.

Element 2.
Identify and
Implement highimpact public
health
interventions to
reduce infectious
diseases.

Element 3.
Develop advance
policies to
prevent, detet,
and control
infectious
diseases.

Figure 8. CDC. (2011). A CDC Framework for Preventing Infectious Diseases: Sustaining the
Essentials and Innovating for the Future. Retrieved from:
https://www.cdc.gov/oid/docs/ID-Framework.pdf
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Appendix K
PARiHS Continua of Dimensions

Figure 9. Adapted from “Enabling the implementation of evidence-based practice: a conceptual
framework,” by A. Kitson, G. Harvey, and B. McCormak. Copyright 1998 by Quality and Safety
in Health Care.
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Appendix L
Pre and Post Quiz Questions
Please Circle: Are you a RN or NT?
1. True or False: It is expected that after administering blood products, the needle-less
endcap must be changed?
2. Changing the needleless endcap after blood administration is important because:
a. The administration of blood products is an independent risk factor for CLABSI
and changing the endcap can help prevent this.
b. Microorganisms grow easily in blood, leading to infections such as CLABSI.
c. The endcap has to be changed every 24 hours, so it is best to change after blood
products.
d. A and B
e. All of the above
3. When planning out your day, what patient should be bathed first?
a. A patient with a peripheral IV catheter who also has a foley in place.
b. A patient that will be going to surgery today and has a peripheral catheter in
place.
c. A patient with a central line that requires CHG bathing.
4. CLABSI can be prevented many ways, what is one way that you can help prevent
CLABSI?
a. Ask about removing unnecessary central lines in daily rounds
b. Wear sterile gloves for all procedures when accessing the central line.
c. Preforming daily central line dressing changes.
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Appendix M
Data Collection Spreadsheet Format
Observation of Patient daily rounds: Did the RN ask about central line removal?
Number of Patients
Did the RN ask about Did the DNP Student
Barrier to
Seen
Line Removal?
provide follow up in
Implementation
Yes/No
the moment? Yes/No
Identified

EHR Endcaps Audit: Were endcaps changed after blood administration?
Number of Patients
Did the RN chart
Did the DNP Student
Barrier to
Audited
endcaps changed after provide follow up in
Implementation
blood administration? the moment? Yes/No
Identified
Yes/No

EHR CHG Bathing Audit: Were patients with CVC bathed in CHG and given prioritization?
Number of Patients
Audited

Did the RN or NT
chart CHG bathing
for patients with
CVC?

Did the DNP Student
provide follow up in
the moment? Yes/No

Barrier to
Implementation
Identified

Number of CLABSI Occurring During Project Implementation
Number of CLABSI During Implementation
Number of CLABSI 3 months before
Implementation

83

Appendix N
CLABSI Prevention Education Script/Email for Staff
Please read this email and complete the post CLABSI quiz (located in your mailbox). I will also
be present on the unit this week to educate you about our CLABSI prevention plan.
What is a central line-associated bloodstream infection (CLABSI)?
The central line was in place for at least 2 calendar days on the date of event, with day of
device placement being day 1 and the line was also in place on the date of event or the day
before.
If central line was in place for at least 2 calendar days and then removed, the date of event of
the laboratory-confirmed bloodstream infection must be the day of discontinuation or the next
day to be a CLABSI.
CDC. (2017a). Bloodstream infection event (central line-associated bloodstream infection
and non-central line-associated bloodstream infection). Retrieved from:
https://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf
What are evidence-based interventions to decrease CLABSI?
• The administration of blood products is a risk factor for CLABSI. Changing the endcap can
help prevent CLABSI. Microorganisms grow easily in blood, leading to infections such as
CLABSI. Per protocol: central line end caps should be changed after blood administration
and documented in EPIC.
• Bathing patients with central lines daily in 2% chlorhexidine (CHG) can reduce CLABSI.
• Performing appropriate hand hygiene.
• Asking daily if the central line can be removed.
This unit has a high use of central line catheters and has seen an increase in CLABSI.
• Areas needing improvement: Changing and documenting endcaps in EPIC after blood
administration, asking about unnecessary central lines being removed during daily rounds
with the interdisciplinary team, and prioritizing CHG bathing on patients with central venous
catheters.
To prevent CLABSI, a prevention bundle will be implemented January 15 2018.
The Bundle Includes:
• RNs will change and document endcaps in EPIC after blood administration. In the Box
below type “endcaps changed after blood”. Do not change the endcaps changed date.
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•

RNs will ask about unnecessary central lines being removed during daily rounds with the
interdisciplinary team, including the physician.

•

RNs and NTs will prioritize and provide CHG bathing to patients with CVCs daily.

•

After this educational session, please take time to fill out the quiz in your mailboxh and
turn in to Christina Winkelman’s mailbox.

•

Another CLABSI email will following as a reminder.

•

Please contact me if you would like additional information about CLABSI prevention.

If you have any questions please contact Christina Winkelman at winkelmc@mail.gvsu.edu.
Thank You,
Christina Winkelman
DNP Student Grand Valley State University
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Appendix O
CLABSI Intervention Email for Staff
Implementing a CLABSI Prevention Bundle
Hello Colleagues,
Our unit will start using a 3-part CLABSI prevention bundle on January 15, 2018. CLABSI
prevention bundles are evidence-based and help prevent CLABSI.
This includes:
1. RNs will change endcaps and document in the EHR after blood administration.
2. RNs will ask if any unnecessary central lines could be removed during daily rounds with the
interdisciplinary team.
3. RNs and NTs will prioritize providing daily CHG bathing to patients with CVCs.
I will be evaluating these practice improvements and provide feedback, as it is available. I
understand that this will require a change in your daily work flow and appreciate your efforts to
prevent CLABSI.
If you have any questions please feel free to contact me at winkelmc@mail.gvsu.edu.
Sincerely,
Christina Winkelman
DNP Student at Grand Valley State University
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Appendix P
Project Timeline
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Appendix Q
GVSU IRB Determination
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Appendix R
Project Organization IRB Determination
Will be provided upon request.
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Appendix S
Budget
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Appendix T
CLABSI Prevention Flyer

CLABSI PREVENTION BUNDLE

1. RNs will change endcaps and document in EPIC after blood
administration.
2. RNs will ask about unnecessary central lines being removed
during daily rounds with the interdisciplinary team, including
the physician.
3. RNs and NTs will prioritize and provide CHG bathing to
patients with CVCs daily.

91

Appendix U
Endcap Audit
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Appendix V
Daily Rounds Audit
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Appendix W
CHG Bathing Audit: DNP Student Standards
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Appendix X
CHG Bathing Audit: Unit Standards
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Appendix Y
CLABSI Bundle Policy
“CLABSI prevention during the maintenance period.”
CLABSI Prevention bundles are evidence based and can help reduce CLABSI. The following
three steps will take place for patients who have a central venous catheter(s).
CLABSI Bundle Intervention
1. RNs will change and document

•

Evidence
Receiving blood products through a CVC has shown

endcaps in the EHR after blood

to be an independent risk factor for CLABSI (Hanna

administration.

& Raad, 2001).
•

Blood products provide a welcoming environment
for bacteria to grow.

•

Platelets, a blood product, may increase adherence
of bacteria to the catheter wall.

•

Platelets also pose a risk as several donors contribute
to one transfusion therefore increasing risk for
transferring organisms (Hermann, Albrecht, Mosher,
& Proctor, 1992).

2. RNs will ask about the necessity of

•

A multicenter, phased, cluster-randomized

central lines during daily rounds and

controlled trial implemented a multifaceted

encourage the removal of

intervention including removing unnecessary line to

unnecessary central lines with the

prevent CLABSI and the intervention group saw a

interdisciplinary team, including the

70% reduction in CLABSI (Marsteller et al., 2012).

physician.

•

It is recommended that the need for the central line
be assessed daily in interdisciplinary rounds and that
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unnecessary catheters be removed. In addition,
(Marschall et al., 2014) recommend auditing if
central lines were removed after their intended
purpose is completed.

3. RNs and NTs will prioritize and

•

Skin colonization of bacteria and other organisms

provide CHG bathing to patients with

facilitate the transmission of harmful organisms into

CVCs daily. This will be charted in

the central line. Chlorhexidine gluconate (CHG) can

the EHR.

reduce the skin microbial burden (O’Horo,
Germana, Munoz-Price, & Safdar, 2012).
•

CHG is effective against gram-positive bacteria,
gram-negative bacteria, aerobic and anaerobic
bacteria, and yeasts (Kim et al., 2016).

•

CHG lasts for up to 24 hours (Shah et al., 2016).
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Objectives for Proposal Defense
1. Discuss clinical problem: CLABSI
2. Review organizational assessment
and literature review
3. Review project plan and models
4. used Present results and
5. sustainability plan
Discuss implications for practice,

The Problem
• 84,551 to 203,916 CLABSI are known to
be preventable4
• 10,426 to 25,145 preventable deaths in
the United States that are CLABSI
related4
• Patients with CLABSI are twice as likely
to die as patients without CLABSI5
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The Problem

Average cost of a CLABSI ranges from
$3,700 to $39,0001,2
Annual cost of CLABSI in U.S. ranges
from 960 million to 18.2 billion
dollars3
The Center for Medicare and
Medicaid does not reimburse
hospitals for the cost of CLABSI

Organizational
Assessment
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Burke and Litwin Model7

Organizational Assessment
De-identified data evaluated:
CLABSI deep dive audits
CHG bathing

BMT Rounding shadowed
Central Line Necessity and Removal
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Deep Dive Audits

12.5% (n=1)
no blood via CVC

Yes
No

100% (n=7)
Did not have end caps
changed

87.5% (n=7)
blood via CVC

Chlorhexidine (CHG) Bathing
• June 2017 daily audit for bathing with CHG
Mean of 81.2% (standard deviation [SD]
14.6, N=445) were bathed daily with CHG

• Assessment:
CHG bathing of patients with CVC were
not prioritized before “all” other patients
Overall rate of CHG bathing needed improve

Yes
No
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Central Line Necessity
• During observation of rounding
8 BMT patients with central lines were evaluated
Removal of the central line not discussed in
any of the cases: 0 of 8 (0%)
3 of the 8 patients (37.5%) were to be
discharged within 48 hours

Clinical Question
• What are the “best” evidence-based CLABSI
prevention interventions for CVC
maintenance that are feasible and
sustainable for the organization?
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SWOT Analysis





Strengths
Focus on collaborative and
coordinated care
Support for CLABSI quality
improvement from key
stakeholders
Previous engagement in past
attempts to reduce CLABSI
RN’s engage in frequent hand
washing to prevent infection.













Opportunities
Improving quality and outcomes o
f
care by implementing evidencebased practice
Potential to decrease cost of care
Potential to decrease number of
CLABSI
Improve education provided to
RNs about CLABSI prevention







Weaknesses
New unit undergoing many changes
both at the unit and system level
New electronic health record
implementation
Many RNs are new with less than
one year of experience
High utilization of central venous
catheters
Lack of RN education in the last year
about CLABSI prevention
Employee burnout, retention, and
shortage

Threats
Funding may not be available for
additional CLABSI prevention
interventions
CLABSI prevention interventions
may not be at the forefront with so
many other changes system wide
presently occurring
Potential for lack of “buy in” from
staff members
BMT populations have high
incidence of CLABSI

Literature
Review
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Evidence on CLABSI Toolkits
The Joint Commission16
CDC17
Johns Hopkins University18

The Joint Commission
Catheter hubs, injection ports, connectors disinfected prior to
use
Closed catheter systems are associated with fewer infections
Chlorhexidine with alcohol or 70% alcohol
recommended for disinfecting catheter hubs, in addition
to scrubbing for 15 seconds
All patients in the ICU >2 months of age be bathed daily
with 2% chlorhexidine
Change the administration set immediately after blood
product.
Use aseptic technique when accessing the catheter
Perform daily review of line necessity with prompt
removal of unnecessary CVCs
Perform hand hygiene
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CDC
•
•
•
•
•
•
•
•
•
•

Comply with hand hygiene requirement
Bathe ICU patients >2 months of age with a chlorhexidine preparation daily
Scrub access port/hub with friction before accessing with antiseptic
Use only sterile devices to access catheters; and sterile dressing change
Change gauze dressings every 2-days; semipermeable dressings every 7days
Adults >18 years of age use chlorhexidine impregnated dressing with
FDA clear label that includes indication for central line
Change continuous administration sets <every 4 days, but >every 7 days
If blood products or fat emulsions given change administration set
every 24 hours
If propofol administered change tubing every 6-12 hours or when
vial is changed
Preform a daily audit to determine if the central line is needed.
– Remove unnecessary central lines

Johns Hopkins University
• Ask daily if the central line can be removed
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High Level of Evidence

Evidence-Based Recommendation
• CLABSI Prevention Bundle
Evidence-Based
Decrease CLABSI
Decrease Cost of Care
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DNP Project
Plan

Project Purpose
Implement CLABSI prevention bundle
to reduce/prevent CLABSI
Project Type:
– Quality Improvement
Translate evidence into practice
Improve delivery of care in order to:
Decrease CLABSI
Decrease Cost of Care
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IRB Approval: QI Project
IRB approval from project site
also obtained. Available for
review upon request.

PARIHS Framework

SI=f(E, C,
–Successful implementation is a
function of evidence, context, and
facilitation

111

Implementation Framework
• CDC ID Framework15
Element 1.
Strengthen public
health
fundamentals,
including
infectious disease
surveillance,
laboratory
detection, and
epidemiologic,

Element 2.
Identify and
Implement highimpact public
health
interventions to
reduce infectious
diseases.

Element 3.
Develop advance
policies to
prevent, detect,
and control
infectious

Setting and Resources
Setting: Midwest healthcare organization
with adult oncology population
Resources:
– Technology:
EHR, Email

– People:
RN, NT, providers, administrative staff, statistician

– Materials:
Quizzes, data collection sheets
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Participants
• BMT patients with central venous catheters
• Staff:
– RNs, NTs and clinicians
– Involved in:
• Direct patient care
• Daily patient rounds

Project Objective and Strategies
Implement CLABSI Prevention Bundle:
RNs change and document endcaps in the
electronic health record after blood
administration
RNs ask about the necessity of central lines during
daily rounds; encourage removal of unnecessary
central lines with the interdisciplinary team,
including the physician.
RNs and NTs prioritize and provide CHG bathing
to patients with CVC’s daily
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Project Objectives and Strategies
Provide education to RNs and NTs about CLABSI
and CLABSI prevention: January 8-14th
Pre-Education Quiz
Education via in session meetings
Email
Flyer
Post Education Quiz

Began using evaluation tools on January 15th
Evaluation thru February 15th
Measure outcomes related to quality and
sustainability of the practice change

CLABSI Prevention Education Email
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CLABSI Prevention Education Email

CLABSI Intervention Email

115

Pre and Post Education Quiz

Measurement: Sources of Data and Tools
Data Sources
EHR
– Documentation of CHG Bathing
– Documentation of endcaps changed after blood
administration
Observation of Rounds
Audit and Feedback Provided in the Moment
– Via in person communication
– Via email
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Data Collection Spreadsheet

Steps for Implementation
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Results

Pre-Post Quiz Data
Pre-Quiz: 40 staff members on unit
– 80% Response Rate (n=32 of 40)
– 18 RNs, 7 NTs, 7 RN/NTs
– Mean score on quiz: 76.6% (SD 24.1)

Post-Quiz: 40 staff members on unit
– 75% Response Rate (n=30 of 40)
– 15 RNs, 8 NTs, 7 RN/NTs
– Mean score on quiz: 95.8% (SD 11.5)

19.2% increase in knowledge (small effect)20
– 77.6% to 95.8%; p-Value=0.0015
– Ceiling effect: as already at high rate at baseline
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Endcap Audit
•
•
•
•

18 Blood Products Administered
CVC endcaps changed 88.9% (n=16 of 18)
CVC endcaps not changed 11.1% (n=2 of 18)
Compared to previous data
September 2016 to May 2017
0% N=0 of 7 changed

• 89% increase in endcaps changes
(large effect)20
– 0% to 89,9%; p-Value <0.0001

Endcap Audit
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Daily Rounding Audit
•
•
•
•
•

102 Cases Audited
RN asked about line necessity in 91.3% n=93
RN did not ask in 8.8% n=9
Prior data: RN asked in 0% n=8
91.3% increase in RN asking
about necessity(large effect)20
– 0% to 91.3%; p-Value <0.0001

Daily Rounding Audit

120

CHG Bathing: Unit Standard
Based on “yes” for bathed with CHG
– even if shower, but CHG was not charted, or
– if a patient refused bathing twice in a day; or
– CHG bathing was completed

115 Audits: data missing in 16 cases
83.8% (n=83) had CHG bathing
16.2% (n=16) did not have CHG bathing
2.6% increase in CHG bathing (negligible)20
– 81.2% to 83.8% ; p-Value >0.05
– Compared to June 2017 rate 81.2% (n=361 of 445)

CHG Bathing: Unit Standard
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CHG Bathing: DNP Student Standard
• Based on the DNP student standard of
either “yes” or “no” for:
“Was the patient bathed daily in CHG? ”

• 115 Audits: data missing in 16 cases
63.6% (n=63 of 99) had CHG bathing
36.4% (n=36 of 99) did not have CHG bathing

• No similar prior data for comparison

CHG Bathing: DNP Student Standard
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CLABSI Rates
• 0 CLABSI during implementation (1-month)
• 8 CLABSI during Sep 2016-May 2017 (10-months)
– Rate of 0.8-per month
• Decrease in CLABSI
– From 0.8 per month to 0 per month
• 100% decrease in CLABSI (large effect)20
– Calculation:
• 0.8 (pre-implementation rate) – 0 (post-implementation rate = 0.8
• 0.8 (pre-implementation rate) / 0.8 (#above) = 100% change

Discussion
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Discussion
No CLABSI during implementation
All 3 elements of bundle improved
1. Endcaps 89% improvement
2. Daily Rounds 91.3% improvement
3. CHG 2.6% improvement

CHG bathing: least improvement
– Patients refused
– May need to education to patients
– RN/NT charted shower, forget to chart CHG

Limitations
• Short implementation period
• Small sample size
Unable to generalize to other populations
Hard to evaluate statistical difference

•
•
•
•

Small amount data prior to implementation
New EHR system during implementation
Providers with less buy than expected
Measures without validity or reliability
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Stakeholder Support & Sustainability
• Support
Key Stakeholders: BMT Manger, RNs, NTs

• Sustainability
CLABSI bundle remains in place after
DNP Student project completion.
Creation of CLABSI prevention policy draft
for unit (*see handout)

Implications for Practice
• CLABSI can be prevented
• Evidence supports use of CLABSI
prevention bundles
– Use decreases CLABSI rates

• DNP Project success, 0 CLABSI
during implementation
• Polarity Management: complacency vs. change
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Budget

Dissemination
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Dissemination of Outcomes
•
•
•
•
•
•

Results shared with key stakeholders
Site poster exhibit
3 minute thesis poster presentation
DNP defense
Future presentations/publications
Published to ScholarWorks

DNP Essentials
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Reflection of DNP Essentials
• I: Scientific Underpinnings for Practice
CLABSI bundle created based on evidence
Use of science-based theories to implement

• II: Organizational and Systems Leadership
Meeting with organizational leader
Organizational assessment
Communicate with manager, staff, and providers
Ethical and cultural sensitivity

Reflection of DNP Essentials
III: Clinical Scholarship and Analytical Methods
– Literature review
– Statistics to evaluate data

IV: Information Systems Technology
– Use of the electronic health record
– Communication via email
– Use of Microsoft excel to analyze data

V: Advocacy for Health Care Policy
– Creation of new policy
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Reflection of DNP Essentials
• VI: Interprofessional Collaboration
Collaborate with stakeholders

• VII: Clinical Prevention Population Health
Analyzed specific unit data related to CLABSI

• VIII: Advanced Nursing Practice
Focus on adult/older adult population
Quality improvement project
Acted as consultant

Conclusion
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Conclusion
A Midwest healthcare organization sought
out help to decrease CLABSI
An organizational assessment and
literature review was conducted
The three part CLABSI bundle was implemented.
Results indicate an increase in all 3 parts of
the bundle
Savings of $22,611 and potentially a life
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